https://healthtalks.newsfarma.pt/cpc-2017-programa-diversificado-traz-novidades-na-area-da-cirurgia-cardiaca/2017-03-23T14:17:57+00:00https://healthtalks.newsfarma.pt/cpc-2017-insuficiencia-cardiaca-e-ja-denominada-a-epidemia-do-seculo-xxi/2017-03-23T14:22:02+00:00https://healthtalks.newsfarma.pt/cpc-2017-conheca-os-cursos-praticos/2017-03-23T14:25:06+00:00https://healthtalks.newsfarma.pt/cpc-2017-doentes-com-insuficiencia-cardiaca-sao-cada-vez-mais/2017-03-23T14:29:41+00:00https://healthtalks.newsfarma.pt/cpc-2017-conhecimento-e-um-dos-pilares-do-congresso/2017-03-23T12:39:33+00:00https://healthtalks.newsfarma.pt/cpc-2017-cardioquiz-reforca-espirito-de-equipa/2017-03-23T14:51:24+00:00https://healthtalks.newsfarma.pt/cpc-2017-cuidados-intensivos-cardiacos-destacados-no-programa-cientifico/2017-03-30T11:00:39+01:00https://healthtalks.newsfarma.pt/cpc-2017-imagem-permite-melhores-diagnosticos-de-doencas-cardiacas/2017-03-30T11:09:38+01:00https://healthtalks.newsfarma.pt/cpc-2017-coracao-mediterranico-traz-chef-portugues-ao-congresso/2017-03-30T11:23:13+01:00https://healthtalks.newsfarma.pt/leading-the-heart-leva-participantes-a-pensar-fora-da-caixa/2017-04-03T18:17:53+01:00https://healthtalks.newsfarma.pt/cpc-2017-cardio-arena-apresenta-ideias-inovadoras-na-area-da-cardiologia/2017-04-05T10:28:49+01:00https://healthtalks.newsfarma.pt/cpc-2017-cardiologia-e-uma-arte/2017-04-05T10:33:39+01:00https://healthtalks.newsfarma.pt/area-reservada/2017-04-05T11:42:02+01:00https://healthtalks.newsfarma.pt/cpc-2017-concurso-de-pintura-tem-premio-de-dois-mil-euros/2017-04-11T14:25:32+01:00https://healthtalks.newsfarma.pt/cpc-2017-flash-guidelines-e-uma-das-novidades-desta-edicao/2017-04-11T14:28:36+01:00https://healthtalks.newsfarma.pt/cpc-2017-acreditar-nas-ideias-mais-loucas-pode-ser-a-chave-para-o-sucesso/2017-04-11T14:29:29+01:00https://healthtalks.newsfarma.pt/cpc-2017-sedentarismo-e-um-fator-de-risco-para-a-doenca-cardiovascular/2017-04-13T14:43:35+01:00https://healthtalks.newsfarma.pt/cpc-2017-atletas-olimpicos-portugueses-na-corrida-do-congresso/2017-04-13T14:47:30+01:00https://healthtalks.newsfarma.pt/fibrilhacao-auricular-o-que-e-quais-os-sinais-de-alerta/2017-04-13T17:21:23+01:00https://healthtalks.newsfarma.pt/cpc-2017-eleva-a-fasquia-para-congressos-futuros/2017-04-13T17:25:50+01:00https://healthtalks.newsfarma.pt/instacpc2017-concurso-de-fotografia-no-instagram-premeia-originalidade/2017-04-17T16:47:14+01:00https://healthtalks.newsfarma.pt/cardiotalks-ganha-espaco-fisico-no-cpc-2017/2017-04-18T10:51:58+01:00https://healthtalks.newsfarma.pt/cpc-2017-doencas-valvulares-em-foco/2017-04-18T11:39:39+01:00https://healthtalks.newsfarma.pt/cpc-2017-conheca-a-aplicacao-movel-do-congresso/2017-04-18T11:44:01+01:00https://healthtalks.newsfarma.pt/cpc-2017-morte-subita-discutida-em-mesas-redondas/2017-04-18T11:46:46+01:00https://healthtalks.newsfarma.pt/cpc-2017-medicos-tambem-sao-artistas/2017-04-19T17:25:57+01:00https://healthtalks.newsfarma.pt/cpc-2017-partilha-de-boa-disposicao-no-habitual-jantar-dos-congressistas/2017-04-19T17:31:40+01:00https://healthtalks.newsfarma.pt/insuficiencia-cardiaca-e-fundamental-abordar-rapidamente-os-doentes/2017-04-22T09:54:48+01:00https://healthtalks.newsfarma.pt/diagnostico-e-avaliacao-nao-invasiva-da-doenca-arterial-periferica/2017-04-22T11:52:55+01:00https://healthtalks.newsfarma.pt/suporte-circulatorio-mecanico-em-foco/2017-04-22T12:49:10+01:00https://healthtalks.newsfarma.pt/formacao-em-acessos-vasculares-ecoguiados/2017-04-22T15:25:26+01:00https://healthtalks.newsfarma.pt/marque-na-agenda-fibrilhacao-auricular-e-o-tema-do-primeiro-debate-cardiotalks/2017-04-22T18:47:05+01:00https://healthtalks.newsfarma.pt/bem-vindos-ao-cpc-2017/2017-04-22T19:48:44+01:00https://healthtalks.newsfarma.pt/formacao-em-cardiopatia-e-gravidez/2017-04-23T12:24:14+01:00https://healthtalks.newsfarma.pt/prevencao-e-morte-subita-no-coracao-estruturalmente-normal/2017-04-23T15:03:21+01:00https://healthtalks.newsfarma.pt/debate-cardiotalks-prevalencia-da-fibrilhacao-auricular-em-portugal/2017-04-23T17:25:40+01:00https://healthtalks.newsfarma.pt/a-criatividade-aliada-a-cardiologia/2017-04-23T18:03:21+01:00https://healthtalks.newsfarma.pt/musica-ciencia-e-amizade-marcam-o-inicio-do-cpc-2017/2017-04-23T18:19:30+01:00https://healthtalks.newsfarma.pt/spc-rejuvenescida-e-com-presenca-forte-na-sociedade-civil/2017-04-24T13:27:47+01:00https://healthtalks.newsfarma.pt/compreender-a-fibrilhacao-auricular/2017-04-24T14:21:17+01:00https://healthtalks.newsfarma.pt/simplificar-a-mensagem-e-a-chave-para-uma-comunicacao-em-saude-eficaz/2017-04-24T14:42:27+01:00https://healthtalks.newsfarma.pt/debate-cardiotalks-reducao-da-mortalidade-cardiovascular-em-portugal/2017-04-24T16:32:52+01:00https://healthtalks.newsfarma.pt/desafiando-o-futuro-construir-novos-coracoes/2017-04-24T17:45:39+01:00https://healthtalks.newsfarma.pt/500-participantes-correm-em-nome-da-saude-do-coracao/2017-04-24T17:53:29+01:00https://healthtalks.newsfarma.pt/sindrome-aortica-aguda-os-desafios-na-abordagem-cirurgica/2017-04-25T10:05:44+01:00https://healthtalks.newsfarma.pt/prevencao-secundaria-e-doenca-aterosclerotica/2017-04-25T10:26:37+01:00https://healthtalks.newsfarma.pt/portugal-na-rota-da-reabilitacao-cardiaca-da-europa/2017-04-25T14:00:25+01:00https://healthtalks.newsfarma.pt/cpc-2018-e-2019-continuam-no-caminho-da-inovacao/2017-04-25T15:44:38+01:00https://healthtalks.newsfarma.pt/debate-cardiotalks-seguimento-de-doentes-com-insuficiencia-cardiaca-em-regime-de-ambulatorio/2017-04-25T16:08:43+01:00https://healthtalks.newsfarma.pt/2-400-congressistas-despedem-se-do-cpc-2017/2017-04-25T16:51:37+01:00https://healthtalks.newsfarma.pt/dieta-mediterranica-uma-aliada-do-coracao/2017-05-03T12:14:19+01:00https://healthtalks.newsfarma.pt/insuficiencia-cardiaca-cronica-em-regime-de-ambulatorio/2017-05-03T12:32:36+01:00https://healthtalks.newsfarma.pt/imagem-nas-cardiopatias-congenitas/2017-05-03T12:44:23+01:00https://healthtalks.newsfarma.pt/cpc-2017-missao-cumprida/2017-05-03T13:16:02+01:00https://healthtalks.newsfarma.pt/uma-viagem-pelo-cpc-2017-em-tres-minutos/2017-05-03T13:56:49+01:00https://healthtalks.newsfarma.pt/spc-continuara-o-caminho-da-modernizacao-e-afirmacao-na-sociedade-civil/2017-05-03T14:33:46+01:00https://healthtalks.newsfarma.pt/debate-cardiotalks-ablacao-de-fa-com-isolamento-das-veias-pulmonares/2017-05-03T16:54:50+01:00https://healthtalks.newsfarma.pt/novos-dados-de-evidencia-com-rivaroxabano/2017-05-04T18:52:15+01:00https://healthtalks.newsfarma.pt/reportagem-stent-for-life-sensibiliza-peregrinos-para-o-enfarte/2017-05-10T18:09:21+01:00https://healthtalks.newsfarma.pt/sociedade-portuguesa-de-cardiologia-apoia-luta-contra-o-enfarte/2017-05-11T15:57:05+01:00https://healthtalks.newsfarma.pt/stent-for-life-sensibiliza-peregrinos-para-o-enfarte-agudo-do-miocardio/2018-01-12T06:00:00+00:00https://healthtalks.newsfarma.pt/cruz-vermelha-portuguesa-presta-auxilio-aos-peregrinos-em-43-postos-de-norte-a-sul-do-pais/2017-05-11T17:47:02+01:00https://healthtalks.newsfarma.pt/o-enfarte-nao-pode-esperar-112-uma-linha-que-nos-liga-a-vida/2017-05-11T17:52:47+01:00https://healthtalks.newsfarma.pt/voxpop-o-que-sabem-as-pessoas-sobre-o-enfarte/2017-05-11T18:00:17+01:00https://healthtalks.newsfarma.pt/rivaroxabano-vantagens-dos-noac-na-prevencao-da-fibrilhacao-auricular/2017-05-18T08:49:16+01:00https://healthtalks.newsfarma.pt/23-o-congresso-nacional-de-medicina-interna-uma-sinergia-de-conhecimentos/2017-05-31T12:23:13+01:00https://healthtalks.newsfarma.pt/dr-antonio-barros-veloso-distinguido-com-premio-nacional-de-medicina-interna-2017/2017-05-31T12:37:34+01:00https://healthtalks.newsfarma.pt/rivaroxabano-o-verdadeiro-significado-de-protecao/2017-05-31T12:44:42+01:00https://healthtalks.newsfarma.pt/anticoagulacao-clinicos-devem-ter-em-conta-os-esquemas-de-ajuste-para-selecao-de-dose/2017-05-31T12:47:29+01:00https://healthtalks.newsfarma.pt/e-essencial-discutir-anticoagulacao-com-os-medicos-internistas/2017-05-31T12:49:36+01:00https://healthtalks.newsfarma.pt/em-retrospetiva-imagens-da-atualizacao-de-conhecimentos-em-medicina-interna/2017-05-31T12:51:27+01:00https://healthtalks.newsfarma.pt/mais-valias-de-rivaroxabano-no-tratamento-da-embolia-pulmonar/2017-07-20T17:58:06+01:00https://healthtalks.newsfarma.pt/contribuicao-dos-protocolos-e-do-rivaroxabano-nos-outcomes-dos-doentes-com-tromboembolismo-venoso/2017-07-20T18:16:08+01:00https://healthtalks.newsfarma.pt/eficacia-e-seguranca-de-rivaroxabano-reforcadas/2017-07-21T09:29:52+01:00https://healthtalks.newsfarma.pt/isth-2017-em-imagens-seis-dias-de-atualizacao-em-trombose-e-hemostase/2017-07-21T09:37:46+01:00https://healthtalks.newsfarma.pt/a-grande-novidade-do-congresso-europeu-de-cardiologia/2017-09-04T18:33:00+01:00https://healthtalks.newsfarma.pt/nova-evidencia-cientifica-podera-ter-implicacoes-na-pratica-clinica-dos-especialistas/2017-09-04T18:36:00+01:00https://healthtalks.newsfarma.pt/uma-inovacao-face-a-tradicional-terapeutica-de-antiagregacao/2017-09-04T18:38:00+01:00https://healthtalks.newsfarma.pt/investigacao-interrompida-dois-anos-antes-do-prazo-previsto/2017-09-04T18:39:00+01:00https://healthtalks.newsfarma.pt/esc-2017-cinco-dias-de-atualizacao-cientifica-em-imagens/2017-09-05T09:56:00+01:00https://healthtalks.newsfarma.pt/resultados-do-estudo-compass-apresentados-durante-o-esc-2017/2017-09-05T10:14:00+01:00https://healthtalks.newsfarma.pt/coordenacao-entre-a-cardiologia-e-a-mgf-na-terapeutica-anticoagulante-e-fundamental/2018-01-22T14:55:00+00:00https://healthtalks.newsfarma.pt/este-congresso-e-a-imagem-daquilo-que-devia-acontecer-na-reforma-em-portugal-nos-cuidados-de-saude/2018-01-22T15:38:00+00:00https://healthtalks.newsfarma.pt/a-gestao-do-doente-com-insuficiencia-cardiaca-e-comorbilidades-associadas/2018-01-22T15:42:00+00:00https://healthtalks.newsfarma.pt/prof-doutor-carlos-ramalhao-ha-tres-decadas-na-vanguarda-da-formacao-da-mgf-em-cardiologia/2018-01-22T16:28:00+00:00https://healthtalks.newsfarma.pt/aumento-da-prevalencia-da-doenca-valvular-reforca-importancia-do-papel-da-mgf/2018-01-22T16:32:00+00:00https://healthtalks.newsfarma.pt/jornadas-permitem-uma-partilha-de-conhecimentos-muito-enriquecedora-para-todos/2018-01-22T16:54:00+00:00https://healthtalks.newsfarma.pt/instantes-fotograficos-uma-confluencia-de-saberes-entre-especialidades/2018-01-22T17:25:13+00:00https://healthtalks.newsfarma.pt/30-a-edicao-das-jornadas-de-atualizacao-cardiologica-do-norte-para-mgf-ja-tem-data-marcada/2018-01-22T06:00:00+00:00https://healthtalks.newsfarma.pt/e-possivel-haver-mais-colaboracao-no-sentido-da-formacao-medica-e-da-literacia-em-saude/2018-03-06T12:22:00+00:00https://healthtalks.newsfarma.pt/leaps-by-bayer-um-movimento-que-visa-fazer-avancos-paradigmaticos-nas-ciencias-da-vida/2018-03-06T12:59:00+00:00https://healthtalks.newsfarma.pt/tonic-app-a-aplicacao-movel-profissional-que-conecta-medicos/2018-03-06T13:58:00+00:00https://healthtalks.newsfarma.pt/o-desafio-da-comunicacao-entre-o-medico-e-o-doente-na-era-das-novas-tecnologias/2018-03-06T14:09:00+00:00https://healthtalks.newsfarma.pt/compass-a-abertura-de-uma-nova-avenida-para-a-pratica-clinica-e-para-a-investigacao/2018-03-06T14:27:00+00:00https://healthtalks.newsfarma.pt/comunicacao-e-prosperidade-os-requisitos-chave-para-aumentar-a-colaboracao/2018-03-06T14:58:00+00:00https://healthtalks.newsfarma.pt/leading-the-heart-2018-discute-como-enfrentar-os-desafios-do-presente-olhando-para-o-futuro/2018-03-06T15:10:00+00:00https://healthtalks.newsfarma.pt/doenca-cardiovascular-estavel-o-que-e-que-o-compass-nos-tras-de-novo/2018-03-06T15:23:00+00:00https://healthtalks.newsfarma.pt/leading-the-heart-2018-em-imagens-na-vanguarda-da-anticoagulacao/2018-03-06T15:52:00+00:00https://healthtalks.newsfarma.pt/o-papel-do-rivaroxabano-na-gestao-do-doente-anticoagulado/2018-03-06T16:28:00+00:00https://healthtalks.newsfarma.pt/importancia-da-abordagem-multidisciplinar-e-colaborativa-do-doente-anticoagulado/2018-05-08T15:40:00+01:00https://healthtalks.newsfarma.pt/compass-vem-trazer-uma-resposta-que-estavamos-a-precisar-para-alguns-dos-nossos-doentes/2018-05-08T16:03:00+01:00https://healthtalks.newsfarma.pt/rivaroxabano-uma-opcao-terapeutica-eficaz-em-diferentes-tipos-de-doente/2018-05-10T16:27:00+01:00https://healthtalks.newsfarma.pt/flashes-cpc2018-ambiciona-mais-e-melhores-solucoes-para-os-doentes-cardiovasculares/2018-05-10T16:41:00+01:00https://healthtalks.newsfarma.pt/politica-de-cookies-2/2018-05-22T13:00:41+01:00https://healthtalks.newsfarma.pt/politica-de-privacidade-e-de-protecao-de-dados-pessoais-2/2018-05-22T13:08:42+01:00https://healthtalks.newsfarma.pt/declaracao-de-consentimento-2/2018-05-22T13:09:20+01:00https://healthtalks.newsfarma.pt/a-participacao-portuguesa-na-ultima-decada-tem-sido-muito-honrosa/2018-08-23T17:44:14+01:00https://healthtalks.newsfarma.pt/impacto-da-reabilitacao-cardiaca-apos-enfarte-do-miocardio/2018-08-25T19:36:31+01:00https://healthtalks.newsfarma.pt/instantes-fotograficos-1-esc-2018-da-boas-vindas-a-mais-de-30-mil-especialistas-de-todo-o-mundo/2018-08-25T22:42:14+01:00https://healthtalks.newsfarma.pt/cirurgia-da-valvula-tricuspide-ha-boas-razoes-para-intervir-mais/2018-08-25T23:34:33+01:00https://healthtalks.newsfarma.pt/a-presenca-portuguesa-nesta-grande-comunidade-vai-ser-cada-vez-mais-forte/2018-08-25T23:47:39+01:00https://healthtalks.newsfarma.pt/insuficiencia-cardiaca-falta-de-comunicacao-entre-cuidados-de-saude-tem-consequencias-negativas/2018-08-26T00:08:45+01:00https://healthtalks.newsfarma.pt/sessao-inaugural-esc-2018-um-inicio-inspirador-e-futuristico/2018-08-26T13:24:01+01:00https://healthtalks.newsfarma.pt/apesar-do-risco-hemorragico-continua-a-valer-a-pena-anticoagular-os-doentes/2018-08-26T14:10:44+01:00https://healthtalks.newsfarma.pt/revascularizacao-do-miocardio-doentes-com-fa-tem-pior-prognostico/2018-08-26T18:46:25+01:00https://healthtalks.newsfarma.pt/comunidade-cientifica-portuguesa-reunida-em-cocktail-no-esc/2018-08-26T18:54:20+01:00https://healthtalks.newsfarma.pt/instantes-fotograficos-2-esc-2018-e-palco-da-internacionalizacao-da-cardiologia-portuguesa/2018-08-26T19:19:06+01:00https://healthtalks.newsfarma.pt/programas-de-reabilitacao-cardiaca-em-doentes-muito-idosos/2018-08-27T19:38:54+01:00https://healthtalks.newsfarma.pt/principais-novidades-nas-guidelines-de-2018-da-esc/2018-08-27T19:47:26+01:00https://healthtalks.newsfarma.pt/instantes-fotograficos-3-cardiologistas-de-olhos-postos-na-ciencia/2018-08-27T20:05:56+01:00https://healthtalks.newsfarma.pt/reducao-de-eventos-cardiovasculares-e-da-mortalidade-em-doentes-com-cad-ou-pad/2018-08-27T21:36:15+01:00https://healthtalks.newsfarma.pt/este-e-o-grande-encontro-da-cardiologia-europeia/2018-08-27T22:56:50+01:00https://healthtalks.newsfarma.pt/valor-prognostico-dos-niveis-de-troponina-cardiaca-apos-revascularizacao-cardiaca/2018-08-28T22:22:06+01:00https://healthtalks.newsfarma.pt/regurgitacao-tricuspide-e-revascularizacao-do-miocardio-em-destaque-no-esc-2018/2018-08-28T22:54:42+01:00https://healthtalks.newsfarma.pt/instantes-fotograficos-4-uniao-de-esforcos-para-uma-melhor-saude-cardiaca/2018-08-28T23:03:32+01:00https://healthtalks.newsfarma.pt/insuficiencia-cardiaca-projecoes-apontam-para-um-aumento-do-peso-da-doenca-em-portugal/2018-08-28T23:52:19+01:00https://healthtalks.newsfarma.pt/eficacia-e-seguranca-de-rivaroxabano-no-contexto-de-insuficiencia-cardiaca/2018-08-29T00:23:04+01:00https://healthtalks.newsfarma.pt/melhoria-da-pratica-clinica-novas-guidelines-clarificam-conceitos/2018-08-29T11:04:39+01:00https://healthtalks.newsfarma.pt/instantes-fotograficos-5-congresso-da-esc-despede-se-de-munique-e-ruma-a-paris/2018-08-29T11:19:18+01:00https://healthtalks.newsfarma.pt/aspetos-relevantes-das-novas-guidelines-de-revascularizacao-miocardica/2018-08-29T16:42:06+01:00https://healthtalks.newsfarma.pt/programas-especificos-de-reabilitacao-cardiaca-aumentam-a-qualidade-de-vida-do-doente/2018-08-29T17:12:29+01:00https://healthtalks.newsfarma.pt/dose-reduzida-de-rivaroxabano-em-doentes-com-ic-resultados-do-estudo-commander-hf/2018-08-29T17:21:35+01:00https://healthtalks.newsfarma.pt/envolvimento-dos-doentes-e-uma-mais-valia-na-disseminacao-e-implementacao-das-guidelines/2018-08-30T08:08:29+01:00https://healthtalks.newsfarma.pt/foi-uma-honra-ter-sido-presidente-da-esc/2018-08-30T08:24:37+01:00https://healthtalks.newsfarma.pt/commander-hf-clarifica-aspetos-relacionados-com-a-insuficiencia-cardiaca-descompensada/2018-08-30T19:42:46+01:00https://healthtalks.newsfarma.pt/portugal-com-expressao-muito-forte-nas-estruturas-europeias-da-cardiologia/2018-08-30T20:05:28+01:00https://healthtalks.newsfarma.pt/impacto-da-iniciacao-precoce-de-sacubitril-valsartan-em-doentes-com-ic-descompensada/2018-08-30T20:25:25+01:00https://healthtalks.newsfarma.pt/estudo-attr-act-avancos-na-abordagem-terapeutica-da-miocardiopatia-amiloidotica/2018-09-05T12:51:25+01:00https://healthtalks.newsfarma.pt/e-um-privilegio-fazer-parte-desta-grande-organizacao-na-qualidade-de-past-president/2018-09-05T13:06:40+01:00https://healthtalks.newsfarma.pt/cinco-dias-de-esc-2018-em-dois-minutos/2018-09-05T13:43:40+01:00https://healthtalks.newsfarma.pt/compass-e-commander-hf-dois-estudos-novos-dados-sobre-rivaroxabano/2018-09-05T13:54:29+01:00https://healthtalks.newsfarma.pt/os-momentos-mais-marcantes-do-esc-2018-em-imagens/2018-09-05T14:00:14+01:00https://healthtalks.newsfarma.pt/mais-valias-da-protecao-vascular-no-contexto-da-doenca-arterial-periferica/2018-12-05T11:07:53+00:00https://healthtalks.newsfarma.pt/impacto-da-dose-vascular-de-rivaroxabano-em-doentes-com-doenca-arterial-periferica/2018-12-05T11:18:25+00:00https://healthtalks.newsfarma.pt/abordagem-multidisciplinar-em-beneficio-do-doente-com-pad/2018-12-05T11:30:02+00:00https://healthtalks.newsfarma.pt/reducao-de-eventos-cardiovasculares-e-da-mortalidade-em-doentes-com-cad-e-pad/2018-12-05T11:49:15+00:00https://healthtalks.newsfarma.pt/compass-versus-commander-hf-novos-dados-sobre-protecao-vascular/2018-12-05T12:12:17+00:00https://healthtalks.newsfarma.pt/bastonario-da-om-realca-trabalho-notavel-das-jornadas-com-30-anos-a-servir-a-qualidade-da-medicina/2019-01-24T14:46:45+00:00https://healthtalks.newsfarma.pt/cada-vez-mais-partimos-para-uma-medicina-individualizada-no-tratamento-de-doentes-com-risco-cardiovascular/2019-01-24T14:52:04+00:00https://healthtalks.newsfarma.pt/jornadas-de-actualizacao-cardiologica-do-norte-para-mgf-passam-para-dimensao-nacional-com-mais-de-1200-participantes/2019-01-24T14:54:44+00:00https://healthtalks.newsfarma.pt/relacao-entre-a-mgf-e-a-cardiologia-quando-referenciar-ou-nao-para-a-consulta-de-especialidade/2019-01-24T14:57:47+00:00https://healthtalks.newsfarma.pt/ecocardiografia-e-um-exame-muitas-vezes-pedido-por-especialistas-de-mgf-que-pode-causar-duvidas-na-interpretacao/2019-01-24T15:02:55+00:00https://healthtalks.newsfarma.pt/e-fundamental-escolher-os-testes-certos-para-os-doentes-quando-existe-a-suspeita-de-alguma-causa-cardiaca/2019-01-24T15:05:24+00:00https://healthtalks.newsfarma.pt/em-2019-existem-muitas-armas-para-tratar-a-insuficiencia-cardiaca-que-ajudam-a-melhorar-o-prognostico-dos-doentes/2019-01-24T15:07:07+00:00https://healthtalks.newsfarma.pt/jornadas-de-actualizacao-cardiologica-do-norte-para-mgf-permitem-aprendizagem-dos-profissionais-das-duas-especialidades/2019-01-24T15:08:40+00:00https://healthtalks.newsfarma.pt/34-as-jornadas-de-cardiologia-hipertensao-e-diabetes-de-almada-garantem-revisao-dos-avancos-cientificos-de-2018/2019-01-24T17:34:57+00:00https://healthtalks.newsfarma.pt/diabetes-mellitus-o-que-trouxe-de-novo-o-ano-de-2018-para-aplicar-na-pratica-clinica-em-2019/2019-01-25T09:59:43+00:00https://healthtalks.newsfarma.pt/cardiologia-e-medicina-geral-e-familiar-de-maos-dadas-em-prol-de-uma-melhor-pratica-clinica/2019-01-25T10:09:07+00:00https://healthtalks.newsfarma.pt/anticoagulacao-protecao-cardiovascular-a-medida-do-doente/2019-01-25T10:15:07+00:00https://healthtalks.newsfarma.pt/cerca-de-600-especialistas-reunidos-nas-34-as-jornadas-de-cardiologia-hipertensao-e-diabetes-de-almada/2019-01-25T10:32:31+00:00https://healthtalks.newsfarma.pt/estudo-compass-dupla-inibicao-da-trombose-e-uma-estrategia-inovadora/2019-05-07T16:46:27+01:00https://healthtalks.newsfarma.pt/congresso-portugues-de-cardiologia-2019-os-highlights-do-evento/2019-05-07T17:03:18+01:00https://healthtalks.newsfarma.pt/cpc-2019-os-melhores-momentos-do-congresso-xl-em-fotografias/2019-05-07T17:08:02+01:00https://healthtalks.newsfarma.pt/dose-vascular-de-rivaroxabano-no-doente-com-doenca-coronaria-cronica-e-comorbilidades/2019-05-07T17:15:20+01:00https://healthtalks.newsfarma.pt/abordagem-integrada-da-protecao-cardiovascular/2019-05-07T17:18:10+01:00https://healthtalks.newsfarma.pt/doenca-coronaria-cronica-combinacao-entre-rivaroxabano-e-acido-acetilsalicilico-e-segura-e-simples/2019-07-05T17:15:00+01:00https://healthtalks.newsfarma.pt/reconhecimento-do-papel-da-trombina-e-dos-anticoagulantes-no-tratamento-da-doenca-aterosclerotica/2019-07-05T17:38:00+01:00https://healthtalks.newsfarma.pt/bolsas-e-premios-no-9th-challenges-in-cardiology-conheca-os-projetos-vencedores/2019-07-05T18:22:59+01:00https://healthtalks.newsfarma.pt/estudo-compass-abre-nova-expectativa-no-tratamento-da-doenca-coronaria-cronica/2019-07-05T18:46:18+01:00https://healthtalks.newsfarma.pt/9th-challenges-in-cardiology-novidades-e-desafios-discutidos-em-ambiente-de-excelencia/2019-07-05T18:55:26+01:00https://healthtalks.newsfarma.pt/esc-2019-os-participantes-podem-esperar-um-congresso-que-supere-todas-as-expectativas/2019-08-29T17:06:38+01:00https://healthtalks.newsfarma.pt/novas-evidencias-em-doentes-com-enfarte-agudo-do-miocardio-sem-doenca-coronaria-obstrutiva/2019-08-31T19:39:59+01:00https://healthtalks.newsfarma.pt/sindrome-coronario-agudo-desenvolvido-um-modelo-preditivo-de-mortalidade-a-um-ano/2019-08-31T19:52:11+01:00https://healthtalks.newsfarma.pt/tavi-a-baixa-media-de-internamento-e-reflexo-da-evolucao-na-cardiologia-de-intervencao/2019-08-31T20:16:47+01:00https://healthtalks.newsfarma.pt/a-onda-r-como-alteracao-eletrocardiografica-no-coracao-de-atleta/2019-08-31T20:29:19+01:00https://healthtalks.newsfarma.pt/instantes-fotograficos-1-paris-abre-as-portas-do-coracao-a-cardiologia-mundial/2019-08-31T20:46:52+01:00https://healthtalks.newsfarma.pt/novos-anticoagulantes-orais-na-resolucao-de-trombos-intraventriculares/2019-09-01T11:18:30+01:00https://healthtalks.newsfarma.pt/gordura-epicardica-uma-variavel-preditora-de-recidiva-apos-isolamento-das-veias-pulmonares/2019-09-01T14:03:31+01:00https://healthtalks.newsfarma.pt/instantes-fotograficos-2-coracoes-nas-nuvens-no-segundo-dia-de-esc-2019/2019-09-01T17:34:19+01:00https://healthtalks.newsfarma.pt/noac-na-prevencao-do-avc-como-proteger-o-rim-dos-doentes-com-fa/2019-09-01T18:17:27+01:00https://healthtalks.newsfarma.pt/anticoagulacao-no-contexto-do-tev-associado-ao-cancro-o-que-nos-dizem-as-evidencias-de-mundo-real/2019-09-01T22:14:55+01:00https://healthtalks.newsfarma.pt/insuficiencia-cardiaca-evolucao-do-nivel-de-evidencia-nas-recomendacoes-de-classe-c/2019-09-02T07:54:39+01:00https://healthtalks.newsfarma.pt/possivel-relacao-entre-diureticos-tiazidicos-e-aumento-do-risco-de-cancro-de-pele/2019-09-02T10:44:47+01:00https://healthtalks.newsfarma.pt/formas-de-melhorar-a-taxa-de-resposta-da-ressincronizacao-cardiaca-apresentadas-no-esc-2019/2019-09-02T16:11:34+01:00https://healthtalks.newsfarma.pt/instantes-fotograficos-3-o-terceiro-dia-na-escalada-do-conhecimento/2019-09-02T17:24:02+01:00https://healthtalks.newsfarma.pt/mais-valias-dos-noac-na-prevencao-do-avc-em-doentes-com-diabetes/2019-09-02T21:37:30+01:00https://healthtalks.newsfarma.pt/estrategias-de-revascularizacao-do-tronco-comum-nao-protegido-como-causa-do-enfarte-agudo-do-miocardio/2019-09-03T13:49:45+01:00https://healthtalks.newsfarma.pt/impacto-da-revascularizacao-completa-na-mortalidade/2019-09-03T15:03:29+01:00https://healthtalks.newsfarma.pt/fibrilhacao-auricular-antes-e-apos-48-horas-de-internamento/2019-09-03T15:30:08+01:00https://healthtalks.newsfarma.pt/instantes-fotograficos-4-ha-quatro-dias-a-preparar-um-futuro-mais-promissor-para-a-cardiologia/2019-09-03T16:04:17+01:00https://healthtalks.newsfarma.pt/noac-na-prevencao-da-trombose-associada-ao-cancro-uma-opcao-terapeutica-eficaz/2019-09-03T19:02:01+01:00https://healthtalks.newsfarma.pt/apneia-do-sono-uma-comorbilidade-frequente-em-doentes-com-insuficiencia-cardiaca/2019-09-04T10:32:19+01:00https://healthtalks.newsfarma.pt/abordagem-terapeutica-em-doentes-com-hipertensao-pulmonar-tromboembolica-cronica/2019-09-04T11:47:52+01:00https://healthtalks.newsfarma.pt/insuficiencia-cardiaca-otimizacao-da-terapeutica/2019-09-04T15:30:32+01:00https://healthtalks.newsfarma.pt/ic-em-portugal-estamos-a-progredir-mas-queremos-ir-muito-mais-longe-e-ha-muita-coisa-a-fazer/2019-09-04T16:38:57+01:00https://healthtalks.newsfarma.pt/incidencia-de-hipertensao-pulmonar-em-criancas-submetidas-a-correcao-cirurgica-da-coartacao-da-aorta/2019-09-04T16:46:23+01:00https://healthtalks.newsfarma.pt/enfarte-agudo-do-miocardio-quais-os-custos-indiretos-associados/2019-09-04T17:20:51+01:00https://healthtalks.newsfarma.pt/fibrilhacao-auricular-ablacao-tardia-de-taquicardia-av-como-fator-de-risco/2019-09-04T19:12:11+01:00https://healthtalks.newsfarma.pt/incidencia-do-avc-no-mitraclip-uma-revisao-sistematica-e-meta-analise/2019-09-05T08:33:07+01:00https://healthtalks.newsfarma.pt/diabetes-e-pre-diabetes-na-sindrome-coronaria-aguda/2019-09-05T09:09:11+01:00https://healthtalks.newsfarma.pt/recomendacoes-europeias-colocam-os-noac-como-primeira-opcao-no-tratamento-do-tromboembolismo-venoso/2019-09-05T10:50:41+01:00https://healthtalks.newsfarma.pt/uma-viagem-de-dois-minutos-pelo-melhor-do-esc-2019/2019-09-12T11:28:54+01:00https://healthtalks.newsfarma.pt/prof-doutor-lino-goncalves-galardoado-no-esc-2019-uma-distincao-de-toda-a-cardiologia-portuguesa/2019-09-12T13:28:47+01:00https://healthtalks.newsfarma.pt/o-que-dizem-as-novas-guidelines-europeias-de-embolia-pulmonar/2019-09-12T14:15:07+01:00https://healthtalks.newsfarma.pt/o-melhor-do-esc-2019-em-imagens/2019-09-12T16:00:00+01:00https://healthtalks.newsfarma.pt/o-papel-fundamental-da-imagiologia-no-apoio-a-decisao-do-cardiologista-clinico/2019-09-12T17:23:33+01:00https://healthtalks.newsfarma.pt/estrategia-de-dupla-inibicao-da-trombose-na-prevencao-de-eventos-em-subpopulacoes-de-maior-risco/2019-12-11T10:42:28+00:00https://healthtalks.newsfarma.pt/leading-the-heart-2019-da-a-conhecer-a-next-generation-na-medicina-cardiovascular/2019-12-11T11:34:05+00:00https://healthtalks.newsfarma.pt/inteligencia-artificial-e-estudo-compass-dois-exemplos-de-avanco-na-medicina-cardiovascular/2019-12-11T11:46:44+00:00https://healthtalks.newsfarma.pt/estudo-compass-e-a-mudanca-de-paradigma-na-protecao-vascular/2019-12-11T11:53:19+00:00https://healthtalks.newsfarma.pt/o-melhor-do-leading-the-heart-2019-em-imagens/2019-12-11T12:01:12+00:00https://healthtalks.newsfarma.pt/webinar-sobre-a-organizacao-dos-cuidados-de-saude-primarios-no-contexto-da-covid-19/2020-03-24T10:13:50+00:00https://healthtalks.newsfarma.pt/spc-organiza-webinar-dedicado-a-pandemia-covid-19-e-a-doenca-cardiovascular/2020-03-24T11:08:57+00:00https://healthtalks.newsfarma.pt/apifarma-alerta-para-a-importancia-da-utilizacao-responsavel-do-medicamento/2020-03-24T11:21:53+00:00https://healthtalks.newsfarma.pt/divulgada-nova-data-do-congresso-portugues-de-cardiologia-2020/2020-03-24T11:23:58+00:00https://healthtalks.newsfarma.pt/mapa-de-risco-de-propagacao-da-covid-19-por-contagio-comunitario-em-portugal/2020-03-24T11:42:43+00:00https://healthtalks.newsfarma.pt/cardiologia-em-plena-pandemia-nenhum-doente-vai-ser-abandonado/2020-04-17T09:45:23+01:00https://healthtalks.newsfarma.pt/em-plena-pandemia-como-podemos-proteger-os-doentes-em-risco-de-avc-webinar-responde-ao-desafio/2020-04-17T11:02:48+01:00https://healthtalks.newsfarma.pt/mortalidade-aumenta-em-marco-estara-a-covid-19-a-provocar-mais-mortes-do-que-as-oficiais/2020-04-17T11:57:07+01:00https://healthtalks.newsfarma.pt/governo-alerta-os-cidadaos-que-devem-ligar-em-caso-de-emergencia-face-a-reducao-das-chamadas-para-o-112/2020-04-17T12:05:28+01:00https://healthtalks.newsfarma.pt/doentes-cardiovasculares-nao-devem-ignorar-sintomas-por-receio-de-ir-as-urgencias/2020-04-17T12:59:07+01:00https://healthtalks.newsfarma.pt/medidas-e-desafios-na-gestao-da-terapeutica-anticoagulante-em-contexto-de-pandemia/2020-04-23T17:07:34+01:00https://healthtalks.newsfarma.pt/impacto-da-covid-19-havera-relacao-entre-o-aumento-da-mortalidade-e-a-reducao-da-ida-aos-su-por-dcv/2020-04-23T17:22:25+01:00https://healthtalks.newsfarma.pt/spavc-emite-recomendacoes-para-o-tratamento-do-avc-agudo-durante-a-pandemia-covid-19/2020-04-23T18:30:13+01:00https://healthtalks.newsfarma.pt/regime-excecional-nos-medicamentos-receitas-de-seis-meses-renovadas-automaticamente/2020-04-29T12:14:32+01:00https://healthtalks.newsfarma.pt/bayer-promove-sharing-experience-sobre-a-nova-era-na-terapeutica-antitrombotica/2020-06-08T13:16:35+01:00https://healthtalks.newsfarma.pt/o-que-pensa-a-oncologia-acerca-do-tratamento-atual-da-trombose-associada-a-cancro/2020-07-16T08:38:35+01:00https://healthtalks.newsfarma.pt/novas-guidelines-de-profilaxia-e-tratamento-de-tev-associado-ao-cancro-incorporam-doacs-como-terapeutica-anticoagulante/2020-07-16T12:06:18+01:00https://healthtalks.newsfarma.pt/risco-trombotico-e-hemorragico-no-doente-com-covid-19-recomendacoes-para-a-pratica-clinica/2020-07-16T12:13:58+01:00https://healthtalks.newsfarma.pt/em-tempos-de-covid-19-webinar-partilha-conselhos-praticos-para-estar-em-casa-sem-estar-imobilizado/2020-07-16T12:26:16+01:00https://healthtalks.newsfarma.pt/the-trilogy-of-vascular-disease-ii-uma-sessao-sharing-experience-a-nao-perder/2020-09-18T14:57:42+01:00https://healthtalks.newsfarma.pt/novidades-impactantes-no-tratamento-da-doenca-arterial-coronaria-e-doenca-arterial-periferica/2020-09-21T11:52:35+01:00https://healthtalks.newsfarma.pt/vericiguat-um-novo-caminho-para-o-tratamento-dos-doentes-com-ic/2020-09-21T12:13:10+01:00https://healthtalks.newsfarma.pt/finerenona-atingiu-o-endpoint-primario-de-eficacia-no-estudo-de-fase-iii-fidelio-dkd/2020-09-21T12:19:35+01:00https://healthtalks.newsfarma.pt/esc-2020-um-formato-diferente-a-qualidade-cientifica-de-sempre/2020-09-30T15:09:07+01:00https://healthtalks.newsfarma.pt/european-society-of-cardiology-publica-pela-primeira-vez-guidelines-na-area-da-cardiologia-desportiva/2020-09-30T15:29:29+01:00https://healthtalks.newsfarma.pt/vericiguat-no-tratamento-da-icfer-em-doentes-graves-o-que-dizem-os-dados-do-estudo-victoria/2020-09-30T15:41:07+01:00https://healthtalks.newsfarma.pt/otimizar-a-prevencao-e-proteger-o-insubstituivel-nos-doentes-com-fa/2020-10-02T11:17:13+01:00https://healthtalks.newsfarma.pt/rivaroxabano-eficaz-em-todos-os-cenarios-associados-ao-tev/2020-10-02T12:01:14+01:00https://healthtalks.newsfarma.pt/ep-1-switch-terapeutico-de-avk-para-noac-em-doentes-com-fibrilhacao-auricular-nao-valvular/2021-01-07T15:28:30+00:00https://healthtalks.newsfarma.pt/ep-2-tromboembolismo-venoso-as-mais-valias-dos-noac-na-extensao-do-tratamento/2021-01-21T17:38:53+00:00https://healthtalks.newsfarma.pt/simposio-bayer-diabetes-e-fa-como-desligar-a-bomba-relogio/2021-03-02T12:21:16+00:00https://healthtalks.newsfarma.pt/orientacao-clinica-sobre-o-diagnostico-prevencao-e-tratamento-do-tromboembolismo-venoso-em-doentes-hospitalizados-com-covid-19/2021-03-02T12:27:36+00:00https://healthtalks.newsfarma.pt/prevencao-otimizada-do-avc-no-doente-com-fanv-atraves-do-controlo-dos-fatores-de-risco-vascular-e-da-anticoagulacao-adequada/2021-03-02T12:29:32+00:00https://healthtalks.newsfarma.pt/o-impacto-da-covid-19-no-diagnostico-tratamento-e-reabilitacao-do-avc/2021-03-02T12:31:53+00:00https://healthtalks.newsfarma.pt/ep-3-da-prevencao-do-avc-ao-tratamento-o-papel-dos-noac/2021-03-23T08:28:37+00:00https://healthtalks.newsfarma.pt/xarelto-r-dose-vascular-25mg-duas-vezes-dia-em-combinacao-com-a-aspirina-gr-r-passa-a-ser-comparticipado-a-partir-de-1-de-maio/2021-04-08T10:24:33+01:00https://healthtalks.newsfarma.pt/ensaio-compass-mostrou-superioridade-significativa-da-associacao-do-rivaroxabano-e-aspirina-versus-aspirina-em-monoterapia-na-prevencao-secundaria-de-eventos-cardiovasculares/2021-04-08T10:41:03+01:00https://healthtalks.newsfarma.pt/marque-na-sua-agenda-congresso-portugues-de-cardiologia-2021/2021-04-08T10:47:51+01:00https://healthtalks.newsfarma.pt/aterosclerose-responsavel-por-122-do-total-de-anos-de-vida-perdidos-em-portugal/2021-04-08T11:02:32+01:00https://healthtalks.newsfarma.pt/custos-da-aterosclerose-representam-11-da-despesa-corrente-em-saude-em-portugal/2021-04-08T11:13:58+01:00https://healthtalks.newsfarma.pt/ja-conhece-o-programa-de-atualizacao-em-terapeutica-antitrombotica-challenges-in-cardiology/2021-04-08T11:25:45+01:00https://healthtalks.newsfarma.pt/dose-vascular-do-rivaroxabano-25-mg-bid-com-asprina-100-mg-eficaz-no-controlo-da-doenca-coronaria-e-doenca-arterial-periferica/2021-10-11T15:55:22+01:00https://healthtalks.newsfarma.pt/resultados-dos-estudos-compass-e-voyager-mudam-paradigma-do-controlo-farmacologico-da-doenca-coronaria-e-doenca-arterial-periferica/2021-10-11T15:57:48+01:00https://healthtalks.newsfarma.pt/dose-vascular-do-rivaroxabano-25-mg-bid-com-aspirina-100-mg-pode-beneficiar-todos-os-doentes-com-doenca-coronaria-e-ou-arterial-periferica/2021-10-11T16:00:57+01:00https://healthtalks.newsfarma.pt/comparticipacao-da-dose-vascular-do-rivaroxabano-na-doenca-arterial-coronaria-motivada-pelos-resultados-do-estudo-compass/2021-10-11T16:08:11+01:00https://healthtalks.newsfarma.pt/dose-vascular-do-rivaroxabano-25-mg-bid-com-aspirina-100-mg-uma-nova-protecao-para-doentes-em-risco-de-novo-evento-cardiovascular/2021-10-11T16:11:11+01:00https://healthtalks.newsfarma.pt/relevancia-clinica-de-vericiguat-para-doentes-com-insuficiencia-cardiaca-de-fracao-de-ejecao-com-evento-de-descompensacao/2021-10-29T15:41:56+01:00https://healthtalks.newsfarma.pt/comparticipacao-da-dose-vascular-do-rivaroxabano-na-doenca-arterial-coronaria-motivada-pelos-resultados-do-estudo-compass-2/2021-10-29T15:50:12+01:00https://healthtalks.newsfarma.pt/vericiguat-uma-nova-opcao-farmacologica-para-reduzir-a-carga-da-icfer/2021-10-29T15:56:18+01:00https://healthtalks.newsfarma.pt/consideracoes-sobre-o-potencial-terapeutico-do-vericiguat-no-tratamento-de-doentes-com-ic-fer-apos-um-evento-de-descompensacao/2021-10-29T15:59:34+01:00https://healthtalks.newsfarma.pt/novo-tratamento-para-insuficiencia-cardiaca-cronica-sintomatica-vericiguat-aprovado-na-eu/2021-11-02T15:32:08+00:00https://healthtalks.newsfarma.pt/beneficio-clinico-do-vericiguat-no-doente-com-ic-fer-a-luz-da-evidencia/2022-05-19T12:36:04+01:00https://healthtalks.newsfarma.pt/os-quatro-pilares-para-o-tratamento-da-icfer/2022-05-19T12:53:02+01:00https://healthtalks.newsfarma.pt/anticoagulantes-e-antiagregantes-combinados-opiniao-de-uma-especialista-de-medicina-geral-e-familiar/2022-05-19T16:13:37+01:00https://healthtalks.newsfarma.pt/doenca-arterial-coronaria-e-periferica-hora-de-mudar/2022-05-19T16:15:08+01:00https://healthtalks.newsfarma.pt/em-busca-do-risco-cardiovascular-nos-doentes-com-doenca-arterial-coronaria-e-periferica/2022-05-19T16:43:14+01:00https://healthtalks.newsfarma.pt/hipocoagulacao-oral-e-um-tema-que-ocupa-muito-a-ciencia/2022-06-02T10:22:05+01:00https://healthtalks.newsfarma.pt/e-um-livro-para-ajudar-a-tomar-decisoes-de-forma-adequada-na-anticoagulacao/2022-06-02T10:24:20+01:00https://healthtalks.newsfarma.pt/livro-a-hipocoagulacao-oral-no-dia-a-dia-reune-especialistas-de-diferentes-areas/2022-06-02T10:25:19+01:00https://healthtalks.newsfarma.pt/dois-grandes-estudos-de-rivaroxabano-apoiam-eficacia-da-inibicao-de-via-dupla-em-doentes-com-doenca-arterial-coronaria-e-ou-periferica/2022-06-02T10:42:30+01:00https://healthtalks.newsfarma.pt/lancamento-do-livro-a-hipocoagulacao-oral-no-dia-a-dia-em-instantes-fotograficos/2022-06-03T11:34:21+01:00https://healthtalks.newsfarma.pt/vericiguat-um-farmaco-diferente-para-o-tratamento-de-doentes-com-agravamento-de-ic-cronica/2022-06-20T16:14:44+01:00https://healthtalks.newsfarma.pt/mais-valias-de-vericiguat-no-tratamento-de-doentes-com-worsening-heart-failure/2022-06-20T16:24:38+01:00https://healthtalks.newsfarma.pt/reducao-do-endpoint-combinado-de-morte-cv-e-internamento-por-ic-descompensada-com-vericiguat/2022-06-20T16:27:15+01:00https://healthtalks.newsfarma.pt/vericiguat-uma-nova-opcao-para-doentes-com-icfer-com-terapeutica-standard-of-care/2022-06-20T16:47:07+01:00https://healthtalks.newsfarma.pt/vericiguat-uma-arma-terapeutica-que-marca-o-ponto-de-viragem-do-worsening-heart-failure/2022-07-05T11:53:25+01:00https://healthtalks.newsfarma.pt/repensar-o-agravamento-da-ic-para-melhorar-o-prognostico-a-arte-de-gestao-do-doente-complexo/2022-07-05T12:01:36+01:00https://healthtalks.newsfarma.pt/prevencao-das-rehospitalizacoes-uma-discussao-aprofundada-a-luz-de-novas-evidencias/2022-07-05T12:11:36+01:00https://healthtalks.newsfarma.pt/congresso-esc-hfa-e-reuniao-heart-failure-debates-complementares-com-o-doente-no-centro-da-discussao/2022-07-05T12:17:48+01:00https://healthtalks.newsfarma.pt/construir-uma-rede-de-cuidados-em-que-a-abordagem-integrada-chegue-a-todos-os-doentes-com-insuficiencia-cardiaca/2022-07-05T12:21:07+01:00https://healthtalks.newsfarma.pt/organizacao-o-maior-desafio-da-insuficiencia-cardiaca-em-portugal/2022-07-05T12:24:00+01:00https://healthtalks.newsfarma.pt/worsening-heart-failure-conceito-e-tratamento-para-a-prevencao-de-eventos-com-vericiguat/2022-10-04T19:03:09+01:00https://healthtalks.newsfarma.pt/momento-para-agir-e-se-o-seu-doente-precisar-de-uma-estrategia-diferente-apos-um-evento-de-descompensacao-da-icfer/2022-10-04T19:11:53+01:00https://healthtalks.newsfarma.pt/beneficios-adicionais-de-vericiguat-na-abordagem-terapeutica-precoce-e-personalizada-ao-doente-apos-um-evento-de-descompensacao-de-ic/2022-11-02T16:03:15+00:00https://healthtalks.newsfarma.pt/otimizacao-da-terapeutica-do-doente-com-insuficiencia-cardiaca-cronica-sintomatica-com-vericiguat/2022-11-02T16:05:42+00:00https://healthtalks.newsfarma.pt/certezas-e-incertezas-na-prevencao-do-avc-cardioembolico-e-do-avc-aterotrombotico/2022-11-04T10:24:29+00:00https://healthtalks.newsfarma.pt/rivaroxabano-muitos-beneficios-e-um-futuro-sem-fim-a-vista/2022-11-04T10:26:57+00:00https://healthtalks.newsfarma.pt/o-potencial-da-inibicao-do-fator-xi-na-prevencao-da-trombose/2022-11-04T10:29:50+00:00https://healthtalks.newsfarma.pt/leading-the-heart-um-evento-inovador-e-uma-oportunidade-de-partilhar-experiencias/2022-11-29T16:46:41+00:00https://healthtalks.newsfarma.pt/multidisciplinaridade-e-prevencao-as-palavras-chave-do-leading-the-heart-2022/2022-11-29T16:51:33+00:00https://healthtalks.newsfarma.pt/rivaroxabano-em-dose-vascular-o-que-nos-diz-o-estudo-compass/2022-11-29T16:54:03+00:00https://healthtalks.newsfarma.pt/prevencao-do-avc-aterosclerotico-abordagem-deve-ser-individualizada-e-de-acordo-com-o-risco-de-eventos/2022-11-29T16:57:55+00:00https://healthtalks.newsfarma.pt/tratamento-e-prevencao-de-eventos-importancia-de-capacitar-os-doentes-e-coloca-los-no-centro-da-decisao/2022-11-29T17:15:34+00:00https://healthtalks.newsfarma.pt/leading-the-heart-foco-na-partilha-de-experiencias-e-na-prevencao-a-forma-mais-inteligente-de-tratar/2022-11-29T17:19:59+00:00https://healthtalks.newsfarma.pt/leading-the-heart-um-evento-diferenciador-que-promove-o-trabalho-de-equipa/2022-11-29T17:25:32+00:00https://healthtalks.newsfarma.pt/um-doente-informado-e-um-doente-com-melhor-prognostico/2022-11-29T17:35:15+00:00https://healthtalks.newsfarma.pt/a-importancia-da-acessibilidade-no-contacto-com-o-doente-e-com-a-mgf/2022-11-29T17:37:04+00:00https://healthtalks.newsfarma.pt/temos-ferramentas-que-nos-permitem-fazer-mais-na-prevencao-do-avc/2022-11-29T17:38:27+00:00https://healthtalks.newsfarma.pt/o-desafio-de-abordar-o-doente-como-um-todo/2022-11-29T17:40:22+00:00https://healthtalks.newsfarma.pt/portugueses-com-insuficiencia-cardiaca-ja-podem-usufruir-dos-beneficios-de-vericiguat-verquvo/2023-03-06T12:41:52+00:00https://healthtalks.newsfarma.pt/doentes-com-ic-frustrados-com-a-perda-de-autonomia-mas-confiantes-em-terapeuticas-mais-eficazes/2023-03-06T14:23:16+00:00https://healthtalks.newsfarma.pt/repensar-a-insuficiencia-cardiaca-em-portugal-novas-respostas/2023-03-06T14:41:46+00:00https://healthtalks.newsfarma.pt/organizacao-dos-cuidados-de-saude-e-novas-terapeuticas-para-melhorar-o-prognostico-em-ic/2023-03-06T15:32:25+00:00https://healthtalks.newsfarma.pt/esforcos-conjuntos-para-contrariar-a-mortalidade-elevada-em-ic/2023-03-06T15:39:45+00:00https://healthtalks.newsfarma.pt/ensaio-victoria-vericigaut-reduz-risco-absoluto-de-hospitalizacao-ou-morte-nos-doentes-com-icfer-descompensada/2023-03-06T15:47:05+00:00https://healthtalks.newsfarma.pt/a-arma-terapeutica-com-resultados-de-eficacia-e-seguranca-que-muda-o-curso-da-doenca/2023-05-11T10:24:02+01:00https://healthtalks.newsfarma.pt/o-panorama-atual-e-futuro-da-icfer-com-vericiguat/2023-05-11T10:30:26+01:00https://healthtalks.newsfarma.pt/a-resposta-a-curto-prazo-para-uma-vida-melhor-no-doente-com-icfer/2023-05-11T10:32:19+01:00https://healthtalks.newsfarma.pt/anticoagular-em-doentes-com-fibrilhacao-auricular/2023-06-01T10:35:47+01:00https://healthtalks.newsfarma.pt/tromboembolismo-venoso-diagnostico-e-abordagem-terapeutica/2023-06-01T10:47:55+01:00https://healthtalks.newsfarma.pt/ter-medo-de-nao-anticoagular-uma-atitude-clinica-a-adotar/2023-06-01T11:02:05+01:00https://healthtalks.newsfarma.pt/certezas-e-incertezas-na-prevencao-do-avc-cardioembolico-e-aterosclerotico-na-jac-2023/2023-06-05T15:06:21+01:00https://healthtalks.newsfarma.pt/rastrear-a-fa-e-anticoagular-o-doente-idoso-em-risco-de-quedas/2023-06-05T15:13:29+01:00https://healthtalks.newsfarma.pt/highlights-do-primeiro-dia-do-heart-failure-congress/2023-07-11T12:45:27+01:00https://healthtalks.newsfarma.pt/vericiguat-um-dos-cinco-pilares-da-terapeutica-da-icfer/2023-07-11T12:48:18+01:00https://healthtalks.newsfarma.pt/estudo-victoria-revelou-os-beneficios-da-adicao-de-vericiguat-a-gdmt-em-doentes-com-worsening-heart-failure/2023-07-11T13:11:08+01:00https://healthtalks.newsfarma.pt/o-fator-xia-como-alvo-terapeutico-na-prevencao-do-avc/2023-12-04T16:49:46+00:00https://healthtalks.newsfarma.pt/dicas-praticas-de-gestao-do-doente-com-fibrilhacao-auricular-no-consultorio/2023-12-04T16:56:39+00:00https://healthtalks.newsfarma.pt/fibrilhacao-auricular-mais-valias-de-rivaroxabano-no-tratamento-e-papel-do-medico-de-familia-no-diagnostico-e-seguimento-do-doente/2023-12-04T17:02:59+00:00https://healthtalks.newsfarma.pt/comparticipacao-de-vericiguat-vai-facilitar-a-adesao-terapeutica-e-a-entrega-do-farmaco-aos-doentes/2024-01-31T10:21:14+00:00https://healthtalks.newsfarma.pt/comparticipacao-de-vericiguat-um-passo-importante-no-tratamento-dos-doentes-que-vivem-com-insuficiencia-cardiaca-cronica/2024-02-07T14:24:55+00:00https://healthtalks.newsfarma.pt/tratamento-da-ic-cronica-sintomatica-prevencao-de-eventos-e-morte-cardiovascular-com-vericiguat-e-agora-comparticipada/2024-02-08T10:42:55+00:00https://healthtalks.newsfarma.pt/fora-do-hospital-e-em-seguranca-victoria-o-estudo-que-demonstrou-a-eficacia-de-vericiguat-no-tratamento-do-doente-com-icfer-apos-descompensacao/2024-02-08T10:51:00+00:00https://healthtalks.newsfarma.pt/utica-a-insuficiencia-cardiaca-e-um-exemplo-da-arte-em-medicina/2024-03-21T10:53:20+00:00https://healthtalks.newsfarma.pt/clinica-de-ic-do-chedv-um-desafio-gratificante-e-uma-solucao-fundamental-para-os-doentes/2024-03-21T11:46:08+00:00https://healthtalks.newsfarma.pt/worsening-heart-failure-este-programa-enquadra-se-na-ambicao-dos-challenges-in-cardiology/2024-04-29T13:08:00+01:00https://healthtalks.newsfarma.pt/otimizacao-da-terapeutica-nos-doentes-com-insuficiencia-cardiaca-quanto-mais-esperamos-maior-o-risco-do-doente/2024-05-21T12:56:41+01:00https://healthtalks.newsfarma.pt/como-prevenir-descompensacao-adicional-e-morte-cardiovascular-em-doentes-com-worsening-heart-failure/2024-05-21T14:41:59+01:00https://healthtalks.newsfarma.pt/beneficios-da-utilizacao-do-potencial-quinto-pilar-em-doentes-de-alto-risco-apos-episodio-de-worsening-heart-failure/2024-05-21T14:48:31+01:00https://healthtalks.newsfarma.pt/reduzir-o-risco-residual-do-doente-com-insuficiencia-cardiaca-a-arma-terapeutica-disponivel-atualmente-que-deve-ser-acrescentada-a-terapeutica-modificadora-de-prognostico/2024-05-21T15:04:50+01:00https://healthtalks.newsfarma.pt/challenges-in-cardiology-uma-plataforma-cada-vez-mais-abrangente-e-um-modelo-de-sucesso/2024-07-12T09:30:31+01:00https://healthtalks.newsfarma.pt/lipidologia-e-risco-cardiovascular-nao-podemos-julgar-os-nossos-doentes-a-olho/2024-07-12T09:38:05+01:00https://healthtalks.newsfarma.pt/extremamente-complexo-e-desafiante-abordagem-a-pessoa-com-diabetes-e-doenca-cardiovascular/2024-07-12T09:41:49+01:00https://healthtalks.newsfarma.pt/beneficios-cardiovasculares-do-treino-de-forca/2024-07-12T09:46:39+01:00https://healthtalks.newsfarma.pt/challenges-in-cardiology-a-14-a-edicao-em-instantes-fotograficos/2024-07-12T09:52:03+01:00https://healthtalks.newsfarma.pt/ter-o-doente-na-equipa-faz-parte-do-nosso-adn/2024-09-05T10:15:30+01:00https://healthtalks.newsfarma.pt/um-projeto-extremamente-entusiasmante-e-emocionalmente-desafiante-a-experiencia-da-clinica-de-insuficiencia-cardiaca-da-ulsge/2024-09-05T10:45:09+01:00https://healthtalks.newsfarma.pt/uma-abordagem-uniica-a-insuficiencia-cardiaca/2025-02-05T13:26:52+00:00https://healthtalks.newsfarma.pt/e-preciso-atingir-o-equilibrio-entre-o-tratamento-o-beneficio-e-a-qualidade-de-vida-que-e-possivel-proporcionar/2024-11-20T18:19:58+00:00https://healthtalks.newsfarma.pt/mais-agilidade-no-esclarecimento-e-resposta-a-profissionais-de-saude/2025-02-06T15:57:36+00:00https://healthtalks.newsfarma.pt/termos/2016-11-27T17:14:35+00:00https://healthtalks.newsfarma.pt/politica-de-cookies/2018-05-22T11:58:19+01:00https://healthtalks.newsfarma.pt/politica-de-privacidade-e-de-protecao-de-dados-pessoais/2018-05-22T12:02:02+01:00https://healthtalks.newsfarma.pt/declaracao-de-consentimento/2018-05-22T12:03:38+01:00https://healthtalks.newsfarma.pt/novo-tratamento-aprovado-na-ue-para-doentes-adultos-com-doenca-renal-cronica-associada-adiabetes-tipo-2/2025-02-03T12:44:15+00:00https://healthtalks.newsfarma.pt/cerca-de-30-dos-casos-de-doenca-renal-terminal-sao-causados-pela-diabetes-alerta-apdp/2025-02-03T12:44:15+00:00https://healthtalks.newsfarma.pt/finerenona-trava-progressao-da-doenca-renal-cronica-na-diabetes-tipo-2/2025-02-03T12:44:15+00:00https://healthtalks.newsfarma.pt/a-nefrologia-sob-o-olhar-da-dr-a-ana-paula-silva/2025-02-03T12:44:15+00:00https://healthtalks.newsfarma.pt/bayer-inicia-estudo-da-terapeutica-combinada-inicial-com-empagliflozina-em-doentes-com-doenca-renal-cronica-e-diabetes-tipo-2/2025-02-03T12:44:15+00:00https://healthtalks.newsfarma.pt/sociedade-portuguesa-de-nefrologia-apela-aos-especialistas-de-outras-areas-para-a-doenca-renal/2025-02-03T12:44:14+00:00https://healthtalks.newsfarma.pt/nefro-gps-vodcasts-sobre-problematicas-da-nefrologia/2025-02-03T12:44:14+00:00https://healthtalks.newsfarma.pt/em-contagem-decrescente-para-o-renal4all/2025-02-03T12:44:14+00:00https://healthtalks.newsfarma.pt/a-reacao-da-spn-por-a-doenca-renal-cronica-nao-ser-prioridade-no-plano-nacional-de-saude-2021-2030/2025-02-03T12:44:14+00:00https://healthtalks.newsfarma.pt/servico-de-nefrologia-do-chuc-celebra-o-seu-46-o-aniversario/2025-02-03T12:44:14+00:00https://healthtalks.newsfarma.pt/novos-dados-demonstram-beneficios-renais-e-cardiovasculares-da-finerenona/2025-02-03T12:44:14+00:00https://healthtalks.newsfarma.pt/a-classificacao-da-causa-da-doenca-renal-e-o-maior-problema/2025-02-03T12:44:14+00:00https://healthtalks.newsfarma.pt/encontro-renal-submissao-de-abstracts-termina-este-mes/2025-02-03T12:44:14+00:00https://healthtalks.newsfarma.pt/alem-do-doente-o-principal-player-na-doenca-renal-cronica-e-o-nefrologista/2025-02-03T12:44:14+00:00https://healthtalks.newsfarma.pt/nefrologista-na-base-da-equipa-multidisciplinar-do-diagnostico-e-controlo-da-paramiloidose/2025-02-03T12:44:14+00:00https://healthtalks.newsfarma.pt/marque-na-agenda-ii-curso-pratico-de-lesao-renal-aguda-na-crianca/2025-02-03T12:44:14+00:00https://healthtalks.newsfarma.pt/anemia-2022-uma-epidemia-oculta-conta-com-o-patrocinio-cientifico-da-spn/2025-02-03T12:44:14+00:00https://healthtalks.newsfarma.pt/dados-apresentados-no-eular-apontam-novas-opcoes-de-tratamento-da-nefrite-lupica/2025-02-03T12:44:14+00:00https://healthtalks.newsfarma.pt/doenca-renal-cronica-e-complicacoes-cardiovasculares-a-gestao-clinica-das-principais-comorbilidades/2025-02-03T12:44:14+00:00https://healthtalks.newsfarma.pt/hemodialise-nao-planeada-e-risco-nutricional-geriatrico-estao-associados-a-piores-outcomes-de-doenca-renal-terminal/2025-02-03T12:44:14+00:00https://healthtalks.newsfarma.pt/creatinina-serica-especifica-da-idade-gestacional-pode-prever-outcomes-adversos-da-gravidez/2025-02-03T12:44:14+00:00https://healthtalks.newsfarma.pt/centro-de-hemodialise-de-valongo-apresenta-elevados-niveis-de-satisfacao/2025-02-03T12:44:14+00:00https://healthtalks.newsfarma.pt/nova-presidencia-da-spn-aumentar-a-literacia-em-saude-da-populacao-e-dos-profissionais-de-saude-e-promover-a-sustentabilidade-financeira/2025-02-03T12:44:14+00:00https://healthtalks.newsfarma.pt/consultas-de-nefrologia-disponiveis-pela-primeira-vez-no-centro-de-saude-de-sao-vicente/2025-02-03T12:44:14+00:00https://healthtalks.newsfarma.pt/unmet-needs-identificadas-no-tratamento-da-doenca-renal-cronica-e-diabetes-tipo-2/2025-02-03T12:44:14+00:00https://healthtalks.newsfarma.pt/encontrada-relacao-entre-niveis-de-aldosterona-e-risco-de-insuficiencia-renal-independente-da-presenca-de-diabetes/2025-02-03T12:44:14+00:00https://healthtalks.newsfarma.pt/doenca-renal-avancada-estudos-concluidos-de-fase-2b-dos-moduladores-seletivos-da-coagulacao-experimentais/2025-02-03T12:44:14+00:00https://healthtalks.newsfarma.pt/aldosterona-esta-associada-a-um-risco-aumentado-de-progressao-da-doenca-renal-cronica/2025-02-03T12:44:14+00:00https://healthtalks.newsfarma.pt/e-ja-este-mes-xxxi-congresso-brasileiro-de-nefrologia/2025-02-03T12:44:14+00:00https://healthtalks.newsfarma.pt/especialistas-reunem-se-para-discutir-nefrologia-em-cuidados-de-saude-primarios/2025-02-03T12:44:14+00:00https://healthtalks.newsfarma.pt/dados-da-analise-fidelity-reforcam-beneficios-cardiorrenais-da-finerenona-o-novo-antagonista-seletivo-dos-recetores-mineralocorticoides-nao-esteroide/2025-02-03T12:44:14+00:00https://healthtalks.newsfarma.pt/em-contagem-decrescente-para-a-reuniao-da-sociedade-portuguesa-de-nefrologia-pediatrica/2025-02-03T12:44:14+00:00https://healthtalks.newsfarma.pt/estudo-relaciona-exposicao-a-poluicao-ambiental-e-risco-de-deterioracao-da-funcao-renal-em-doentes-adultos-com-drc/2025-02-03T12:44:14+00:00https://healthtalks.newsfarma.pt/estudo-de-base-populacional-confirma-eficacia-da-vacinacao-contra-a-covid-19-em-individuos-com-doenca-renal-nao-dependentes-de-dialise/2025-02-03T12:44:14+00:00https://healthtalks.newsfarma.pt/nefrologia-e-anemia-a-perspetiva-de-uma-epidemia-oculta-no-anemia-2022/2025-02-03T12:44:14+00:00https://healthtalks.newsfarma.pt/finerenona-o-futuro-do-tratamento-cardiorrenal/2025-02-03T12:44:14+00:00https://healthtalks.newsfarma.pt/reducao-do-risco-de-eventos-cardiovasculares-e-renais-e-da-mortalidade-com-finerenona-o-que-nos-diz-a-evidencia-atual/2025-02-03T12:44:14+00:00https://healthtalks.newsfarma.pt/encontro-renal-2022-o-espelho-da-nossa-atividade/2025-02-03T12:44:14+00:00https://healthtalks.newsfarma.pt/finerenona-mais-um-passo-para-combater-a-doenca-renal-cronica-na-populacao-com-diabetes-e-um-dos-pilares-da-terapeutica/2025-02-03T12:44:14+00:00https://healthtalks.newsfarma.pt/a-nefrologia-e-a-inteligencia-artificial-o-futuro-da-transplantacao-renal-de-dadores-falecidos/2025-02-03T12:44:14+00:00https://healthtalks.newsfarma.pt/encontro-renal-2022-novos-farmacos-e-nefrologia-verde/2025-02-03T12:44:14+00:00https://healthtalks.newsfarma.pt/save-kidney-save-all-e-o-mote-da-43-a-reuniao-anual-da-korean-society-of-nephrology/2025-02-03T12:44:14+00:00https://healthtalks.newsfarma.pt/marque-na-agenda-xxiii-simposio-de-atualizacao-em-nefrologia/2025-02-03T12:44:14+00:00https://healthtalks.newsfarma.pt/o-papel-da-nefroprotecao-e-do-controlo-da-inflamacao-e-fibrose/2025-02-03T12:44:14+00:00https://healthtalks.newsfarma.pt/a-mudanca-de-paradigma-no-tratamento-da-doenca-renal-diabetica/2025-02-03T12:44:14+00:00https://healthtalks.newsfarma.pt/uma-doenca-silenciosa-e-insidiosa-que-se-torna-pouco-valorizada-e-ate-negligenciada/2025-02-03T12:44:14+00:00https://healthtalks.newsfarma.pt/impacto-do-tratamento-com-finerenona-nos-outcomes-renais-em-doentes-com-dt2-e-drc/2025-02-03T12:44:14+00:00https://healthtalks.newsfarma.pt/validacao-da-kidney-failure-risk-equation-na-populacao-portuguesa/2025-02-03T12:44:14+00:00https://healthtalks.newsfarma.pt/sociedade-portuguesa-de-nefrologia-organiza-curso-de-sedimento-urinario/2025-02-03T12:44:14+00:00https://healthtalks.newsfarma.pt/relacao-indissociavel-entre-diabetes-e-doenca-renal-cronica/2025-02-03T12:44:14+00:00https://healthtalks.newsfarma.pt/proteinuria-elevada-associada-a-eventos-relacionados-com-a-ic-em-doentes-com-fa/2025-02-03T12:44:14+00:00https://healthtalks.newsfarma.pt/estudo-avaliou-o-impacto-do-status-de-ferro-nos-outcomes-renais-apos-o-transplante-de-rim/2025-02-03T12:44:14+00:00https://healthtalks.newsfarma.pt/finerenona-recebe-parecer-positivo-para-expandir-a-doentes-com-drc-e-dt2/2025-02-03T12:44:14+00:00https://healthtalks.newsfarma.pt/qual-o-impacto-ambiental-dos-servicos-de-nefrologia/2025-02-03T12:44:14+00:00https://healthtalks.newsfarma.pt/barreiras-legais-a-individualizacao-da-prescricao-da-dialise/2025-02-03T12:44:14+00:00https://healthtalks.newsfarma.pt/sustentabilidade-ambiental-da-nefrologia/2025-02-03T12:44:14+00:00https://healthtalks.newsfarma.pt/o-futuro-promissor-para-uma-melhor-protecao-cardiorrenal/2025-02-03T12:44:14+00:00https://healthtalks.newsfarma.pt/diabetes-e-doenca-renal-cronica-o-pilar-terapeutico-no-tratamento-corrente-das-pessoas/2025-02-03T12:44:14+00:00https://healthtalks.newsfarma.pt/finerenona-nova-arma-terapeutica-na-protecao-cardiorrenal-das-pessoas-com-diabetes-tipo-2/2025-02-03T12:44:14+00:00https://healthtalks.newsfarma.pt/especialistas-portugueses-e-espanhois-em-nefrologia-pediatrica-reunem-se-no-mes-de-maio/2025-02-03T12:44:14+00:00https://healthtalks.newsfarma.pt/nefrologia-em-dialogo-a-criacao-de-sinergias-com-mgf-medicina-interna-e-cardiologia/2025-02-03T12:44:14+00:00https://healthtalks.newsfarma.pt/dr-a-sofia-correia-de-barros-assume-lideranca-da-associacao-nacional-de-centros-de-dialise/2025-02-03T12:44:14+00:00https://healthtalks.newsfarma.pt/doenca-renal-cronica-spn-pede-que-se-intensifiquem-rastreios-dada-prevalencia-nacional/2025-02-03T12:44:14+00:00https://healthtalks.newsfarma.pt/o-estadiamento-e-a-predicao-da-progressao-da-doenca-renal-cronica/2025-02-03T12:44:14+00:00https://healthtalks.newsfarma.pt/cerca-de-30-das-pessoas-que-iniciam-tratamento-por-dialise-tem-diabetes-alerta-apdp/2025-02-03T12:44:14+00:00https://healthtalks.newsfarma.pt/servico-de-nefrologia-e-transplantacao-renal-do-chuln-reconhecido-segundo-o-modelo-acsa/2025-02-03T12:44:14+00:00https://healthtalks.newsfarma.pt/prevencao-da-doenca-renal-cronica-ensinada-nas-escolas-portuguesas/2025-02-03T12:44:14+00:00https://healthtalks.newsfarma.pt/analise-de-subgrupo-do-estudo-fidelity-demonstra-beneficios-em-pessoas-com-dt2-e-drc-em-estadio-4/2025-02-03T12:44:14+00:00https://healthtalks.newsfarma.pt/sociedades-helveticas-de-diabetologia-e-nefrologia-produzem-documento-de-consenso-sobre-nefropatia-diabetica-no-contexto-da-dt2/2025-02-03T12:44:14+00:00https://healthtalks.newsfarma.pt/recomendacoes-na-doenca-cardiovascular-estabelecida-e-na-doenca-renal/2025-02-03T12:44:14+00:00https://healthtalks.newsfarma.pt/from-bench-to-bedside-o-caminho-da-inovacao-e-a-mudanca-na-pratica-clinica/2025-02-03T12:44:14+00:00https://healthtalks.newsfarma.pt/o-internato-aos-olhos-de-um-interno/2025-02-03T12:44:14+00:00https://healthtalks.newsfarma.pt/doenca-renal-diabetica-progressao-podera-atingir-um-custo-total-de-cerca-de-17-mil-milhoes-de-euros/2025-02-03T12:44:14+00:00https://healthtalks.newsfarma.pt/75-das-pessoas-com-doenca-renal-cronica-sao-hipertensas/2025-02-03T12:44:14+00:00https://healthtalks.newsfarma.pt/finerenona-o-novo-pilar-terapeutico-na-prevencao-de-complicacoes-associadas-a-nefropatia-diabetica/2025-02-03T12:44:14+00:00https://healthtalks.newsfarma.pt/causas-raras-de-doenca-renal-cronica/2025-02-03T12:44:14+00:00https://healthtalks.newsfarma.pt/estamos-a-mudar-a-vida-das-pessoas-e-a-dar-lhes-mais-qualidade-de-vida/2025-02-03T12:44:14+00:00https://healthtalks.newsfarma.pt/o-momento-de-mudanca-de-prognostico-da-doenca-renal-diabetica/2025-02-03T12:44:14+00:00https://healthtalks.newsfarma.pt/finerenona-a-peca-do-puzzle-que-faltava/2025-02-03T12:44:14+00:00https://healthtalks.newsfarma.pt/a-diabetes-e-uma-doenca-em-crescimento-presidente-da-spedm-aborda-doenca-renal-diabetica/2025-02-03T12:44:14+00:00https://healthtalks.newsfarma.pt/o-caminho-da-inovacao-e-a-mudanca-na-pratica-clinica-o-papel-da-finerenona/2025-02-03T12:44:14+00:00https://healthtalks.newsfarma.pt/o-perfil-farmacocinetico-da-finerenona-e-muito-atrativo/2025-02-03T12:44:14+00:00https://healthtalks.newsfarma.pt/hoje-e-um-grande-dia-para-as-pessoas-com-diabetes-tipo-2-e-doenca-renal/2025-02-03T12:44:14+00:00https://healthtalks.newsfarma.pt/a-evolucao-dos-farmacos-para-a-doenca-renal-cronica/2025-02-03T12:44:14+00:00https://healthtalks.newsfarma.pt/diabetes-e-doenca-renal-a-mudanca-de-prognostico-sem-desprestigio-do-controlo-da-glicemia/2025-02-03T12:44:14+00:00https://healthtalks.newsfarma.pt/a-finerenona-sera-um-pilar-na-nefropatia-na-pessoa-com-diabetes/2025-02-03T12:44:14+00:00https://healthtalks.newsfarma.pt/o-servico-de-nefrologia-do-centro-hospitalar-de-setubal-esta-a-mudar/2025-02-03T12:44:14+00:00https://healthtalks.newsfarma.pt/colmatar-as-carencias-da-area-o-foco-do-8-o-curso-intensivo-de-nefrologia-para-nao-nefrologistas/2025-02-03T12:44:14+00:00https://healthtalks.newsfarma.pt/nefrologia-de-ligacao-qual-o-papel-do-nefrologista-e-do-medico-de-mgf/2025-02-03T12:44:14+00:00https://healthtalks.newsfarma.pt/hipertensao-arterial-resistente-sob-a-visao-do-cardiologista/2025-02-03T12:44:14+00:00https://healthtalks.newsfarma.pt/quando-referenciar-para-a-consulta-de-nefrologia/2025-02-03T12:44:14+00:00https://healthtalks.newsfarma.pt/uma-viagem-fotografica-pelo-futuro-do-tratamento-da-doenca-renal-cronica/2025-02-03T12:44:14+00:00https://healthtalks.newsfarma.pt/denervacao-renal-o-terceiro-pilar-do-controlo-da-pressao-arterial/2025-02-03T12:44:14+00:00https://healthtalks.newsfarma.pt/finerenona-a-mudanca-no-panorama-da-doenca-renal-cronica-associada-a-diabetes/2025-02-03T12:44:14+00:00https://healthtalks.newsfarma.pt/um-novo-pilar-no-tratamento-da-doenca-renal-cronica-associada-a-diabetes-e-nao-so-quais-as-mais-valias-de-finerenona/2025-02-03T12:44:14+00:00https://healthtalks.newsfarma.pt/para-a-nefrologia-portuguesa-e-muito-bom-haver-uma-nefrologista-nacional-no-council-da-era/2025-02-03T12:44:13+00:00https://healthtalks.newsfarma.pt/uma-oportunidade-unica-e-urgente-de-pensar-no-futuro-sustentavel-da-nefrologia/2025-02-03T12:44:13+00:00https://healthtalks.newsfarma.pt/o-weekend-effect-existe-efetivamente-na-realidade-clinica-da-lesao-renal-aguda/2025-02-03T12:44:13+00:00https://healthtalks.newsfarma.pt/um-caminho-marcado-pela-diferenca-a-historia-do-servico-de-nefrologia-do-hospital-de-vila-franca-de-xira/2025-02-03T12:44:13+00:00https://healthtalks.newsfarma.pt/maioria-dos-adultos-com-diabetes-nao-faz-testes-de-rastreio-para-a-doenca-renal-cronica/2025-02-03T12:44:13+00:00https://healthtalks.newsfarma.pt/porto-recebe-mais-uma-edicao-do-encontro-renal/2025-02-03T12:44:13+00:00https://healthtalks.newsfarma.pt/encontro-renal-o-momento-de-criar-novos-conceitos-e-estabelecer-protocolos-de-articulacao/2025-02-03T12:44:13+00:00https://healthtalks.newsfarma.pt/xxii-congresso-paulista-de-nefrologia-com-destaque-para-a-inteligencia-artificial/2025-02-03T12:44:13+00:00https://healthtalks.newsfarma.pt/spn-e-apmgf-aliam-se-no-incentivo-a-investigacao-sobre-a-microalbuminuria-nos-csp/2025-02-03T12:44:13+00:00https://healthtalks.newsfarma.pt/maioria-dos-portugueses-nao-sabe-que-a-diabetes-e-a-principal-causa-de-dialise-renal/2025-02-03T12:44:13+00:00https://healthtalks.newsfarma.pt/em-contagem-decrescente-para-o-xxiv-simposio-anual-de-doencas-renais/2025-02-03T12:44:13+00:00https://healthtalks.newsfarma.pt/finerenona-terapeutica-modificadora-de-prognostico-na-doenca-cardiorrenal/2025-02-03T12:44:13+00:00https://healthtalks.newsfarma.pt/despesa-do-estado-por-doente-com-dialise-desceu-21-em-10-anos-apesar-de-aumento-do-numero-de-doentes/2025-02-03T12:44:13+00:00https://healthtalks.newsfarma.pt/erasmus-n-path-um-momento-de-aprendizagem-de-nefrologia-de-diagnostico-e-de-intervencao/2025-02-03T12:44:13+00:00https://healthtalks.newsfarma.pt/anadial-denuncia-falta-de-dialogo-sobre-doenca-renal-cronica/2025-02-03T12:44:13+00:00https://healthtalks.newsfarma.pt/impacto-da-covid-19-nas-unidades-de-hemodialise-em-portugal/2025-02-03T12:44:13+00:00https://healthtalks.newsfarma.pt/diabetes-aumenta-o-risco-de-desenvolver-doenca-renal/2025-02-03T12:44:13+00:00https://healthtalks.newsfarma.pt/um-em-cada-cinco-portugueses-sofre-de-anemia/2025-02-03T12:44:13+00:00https://healthtalks.newsfarma.pt/a-importancia-da-consulta-de-pre-concecao-em-mulheres-com-doenca-renal-cronica/2025-02-03T12:44:13+00:00https://healthtalks.newsfarma.pt/quais-os-dados-do-registo-de-doenca-renal-cronica-2022/2025-02-03T12:44:13+00:00https://healthtalks.newsfarma.pt/encontro-renal-2023-estamos-muito-satisfeitos-com-a-capacidade-de-atrair-mais-de-800-participantes/2025-02-03T12:44:13+00:00https://healthtalks.newsfarma.pt/o-sucesso-do-encontro-renal-2023-sob-a-visao-do-prof-doutor-jose-antonio-lopes/2025-02-03T12:44:13+00:00https://healthtalks.newsfarma.pt/como-modular-a-terapeutica-imunossupressora-nos-doentes-transplantados-renais-com-infecao-ativa/2025-02-03T12:44:13+00:00https://healthtalks.newsfarma.pt/genetica-e-nefrologia-em-debate-no-encontro-renal-2023/2025-02-03T12:44:13+00:00https://healthtalks.newsfarma.pt/qual-o-estado-da-arte-e-as-limitacoes-da-terapia-genetica-nas-doencas-renais/2025-02-03T12:44:13+00:00https://healthtalks.newsfarma.pt/casos-desafiantes-de-gravidez-em-doencas-renais/2025-02-03T12:44:13+00:00https://healthtalks.newsfarma.pt/uma-viagem-fotografica-pelo-encontro-renal/2025-02-03T12:44:13+00:00https://healthtalks.newsfarma.pt/publicada-estrategia-nacional-para-promocao-e-cuidados-na-doenca-renal-cronica/2025-02-03T12:44:13+00:00https://healthtalks.newsfarma.pt/a-vitoria-contra-a-doenca-renal-comeca-na-prevencao/2025-02-03T12:44:13+00:00https://healthtalks.newsfarma.pt/simplicidade-e-eficacia-de-finerenona-no-tratamento-da-doenca-renal-diabetica-a-evidencia-e-o-exemplo-de-mundo-real/2025-02-03T12:44:13+00:00https://healthtalks.newsfarma.pt/escolas-de-leiria-acolhem-iniciativa-de-consciencializacao-para-a-doenca-renal-cronica/2025-02-03T12:44:13+00:00https://healthtalks.newsfarma.pt/infarmed-alerta-para-riscos-de-medicamentos-com-pseudoefedrina-para-hipertensos-e-doentes-renais/2025-02-03T12:44:13+00:00https://healthtalks.newsfarma.pt/nefrologistas-lembram-que-dialise-no-domicilio-representa-uma-opcao-mais-sustentavel-para-os-doentes-e-o-ambiente/2025-02-03T12:44:13+00:00https://healthtalks.newsfarma.pt/estudo-propoe-criterios-para-atualizacao-periodica-do-pagamento-da-hemodialise-em-portugal/2025-02-03T12:44:13+00:00https://healthtalks.newsfarma.pt/protecao-cardiorrenal-com-finerenona-em-debate-no-congresso-portugues-de-diabetes/2025-02-03T12:44:13+00:00https://healthtalks.newsfarma.pt/hospital-de-estarreja-duplica-consulta-de-nefrologia-para-atender-a-norte/2025-02-03T12:44:13+00:00https://healthtalks.newsfarma.pt/a-obesidade-esta-associada-a-progressao-da-drc-independentemente-da-patologia-subjacente/2025-02-03T12:44:13+00:00https://healthtalks.newsfarma.pt/sns-prepara-celebracoes-do-dia-mundial-do-rim/2025-02-03T12:44:13+00:00https://healthtalks.newsfarma.pt/cerca-de-10-das-pessoas-com-diabetes-desenvolvem-doenca-renal/2025-02-03T12:44:13+00:00https://healthtalks.newsfarma.pt/diagnostico-e-prevencao/2025-02-03T12:44:13+00:00https://healthtalks.newsfarma.pt/faz-sentido-repensar-o-financiamento-da-hemodialise-em-portugal/2025-02-03T12:44:13+00:00https://healthtalks.newsfarma.pt/75-das-pessoas-com-doenca-renal-diabetica-sentem-se-preocupadas-com-o-agravamento-da-sua-condicao/2025-02-03T12:44:13+00:00https://healthtalks.newsfarma.pt/premio-atribui-10-mil-euros-a-investigacao-na-doenca-renal/2025-02-03T12:44:13+00:00https://healthtalks.newsfarma.pt/nefrologistas-e-oncologistas-o-papel-da-multidisciplinaridade-no-carcinoma-de-celulas-renais/2025-02-03T12:44:13+00:00https://healthtalks.newsfarma.pt/protecao-cardiorrenal-com-finerenona-da-evidencia-a-pratica-clinica/2025-02-03T12:44:13+00:00https://healthtalks.newsfarma.pt/os-tres-pilares-da-nova-abordagem-a-drc-diabetica/2025-02-03T12:44:13+00:00https://healthtalks.newsfarma.pt/a-finerenona-e-mais-um-elo-na-cadeia-de-protecao-da-doenca-renal/2025-02-03T12:44:13+00:00https://healthtalks.newsfarma.pt/finerenona-um-farmaco-modificador-de-prognostico-especifico-para-doenca-renal-cronica/2025-02-03T12:44:13+00:00https://healthtalks.newsfarma.pt/estrategia-nacional-para-a-promocao-da-saude-renal-e-cuidados-integrados-da-drc-um-caminho-para-melhorar/2025-02-06T15:40:48+00:00https://healthtalks.newsfarma.pt/campanha-pretende-fazer-a-diferenca-na-doenca-renal-e-dar-prioridade-a-um-problema-que-afeta-10-da-populacao-nacional/2025-02-03T12:44:13+00:00https://healthtalks.newsfarma.pt/transplante-renal-atinge-maximo-historico-de-atividade/2025-02-03T12:44:13+00:00https://healthtalks.newsfarma.pt/como-mudar-o-prognostico-cardiorrenal-dos-doentes-com-diabetes-tipo-2-descubra-no-30-o-cnmi/2025-02-03T12:44:13+00:00https://healthtalks.newsfarma.pt/hospital-garcia-de-orta-realiza-procedimento-no-pais-de-acesso-vascular-para-hemodialise/2025-02-03T12:44:13+00:00https://healthtalks.newsfarma.pt/premio-atribui-10-mil-euros-a-investigacao-na-doenca-renal-2/2025-02-03T12:44:13+00:00https://healthtalks.newsfarma.pt/doentes-renais-cronicos-em-dialise-podem-ir-de-ferias/2025-02-03T12:44:13+00:00https://healthtalks.newsfarma.pt/o-novo-pilar-no-tratamento-das-pessoas-com-diabetes-e-drc/2025-02-06T15:38:19+00:00https://healthtalks.newsfarma.pt/temos-uma-opcao-altamente-eficaz-e-modificadora-de-prognostico/2025-02-06T15:36:56+00:00https://healthtalks.newsfarma.pt/melhorar-o-diagnostico-da-drc-para-tratar-melhor/2025-02-06T15:35:54+00:00https://healthtalks.newsfarma.pt/hemodialise-noturna-beneficios-desafios-e-impacto-na-vida-dos-doentes-renais/2025-02-03T12:44:13+00:00https://healthtalks.newsfarma.pt/e-muito-importante-o-rastreio-da-doenca-renal/2025-02-06T15:34:55+00:00https://healthtalks.newsfarma.pt/madeira-recebe-o-encontro-renal-2024/2025-02-03T12:44:13+00:00https://healthtalks.newsfarma.pt/global-aliance-for-kidney-health-lanca-campanha-faca-a-diferenca-na-doenca-renal/2025-02-03T12:44:13+00:00https://healthtalks.newsfarma.pt/sns-financiou-985-dos-tratamentos-de-hemodialise-em-2023/2025-02-03T12:44:13+00:00https://healthtalks.newsfarma.pt/molecula-nova-e-diferenciadora-no-tratamento-de-doenca-renal-cronica-em-dt2/2025-02-06T15:32:48+00:00https://healthtalks.newsfarma.pt/a-finerenona-como-modificador-do-prognostico-cardiorrenal-nos-doentes-com-diabetes-tipo-2/2025-02-03T12:44:13+00:00https://healthtalks.newsfarma.pt/novos-dados-podem-redefinir-o-tratamento-de-doentes-com-ic-com-fracao-de-ejecao-preservada/2025-02-06T14:43:18+00:00https://healthtalks.newsfarma.pt/bayer-inicia-estudo-alpine-1-em-doentes-com-doenca-renal-cronica/2025-02-03T12:44:13+00:00https://healthtalks.newsfarma.pt/clinicas-de-dialise-mantem-se-em-funcionamento-nas-zonas-afetadas-pelos-incendios/2025-02-03T12:44:13+00:00https://healthtalks.newsfarma.pt/nova-analise-de-subgrupo-do-finearts-hf-demonstra-que-doentes-com-ic-e-fracao-de-ejecao-do-ventriculo-esquerdo-%e2%89%a540-que-receberam-finerenona-tiveram-um-risco-reduzido-de-novos-casos-de-diabetes/2025-02-03T12:44:12+00:00https://healthtalks.newsfarma.pt/inovacao-no-tratamento-para-tratar-doentes-com-icfep/2025-02-06T14:38:04+00:00https://healthtalks.newsfarma.pt/estudo-mostra-que-transplantes-renais-sao-seguros-entre-as-pessoas-com-vih/2025-02-03T12:44:12+00:00https://healthtalks.newsfarma.pt/o-encontro-renal-e-o-ponto-mais-alto-da-agenda-cientifica-da-spn/2025-02-06T14:32:52+00:00https://healthtalks.newsfarma.pt/genetica-e-terapeuticas-especificas-os-temas-emergentes-da-reuniao-da-spnp/2025-02-06T14:31:06+00:00https://healthtalks.newsfarma.pt/encontro-renal-2024-regressa-a-madeira-30-anos-depois/2025-02-03T12:44:12+00:00https://healthtalks.newsfarma.pt/tratar-o-rim-e-a-hta-e-tambem-tratar-o-doente-com-diabetes/2025-02-06T14:11:38+00:00https://healthtalks.newsfarma.pt/estudantes-de-medicina-e-nutricao-desafiados-a-criar-receitas-para-pessoas-com-doenca-renal-cronica/2025-02-03T12:44:12+00:00https://healthtalks.newsfarma.pt/save-the-date-5-a-edicao-do-curso-sobre-abordagem-do-acesso-vascular-em-hemodialise-acontece-em-novembro/2025-02-03T12:44:12+00:00https://healthtalks.newsfarma.pt/congresso-mundial-de-nefrologia-anuncia-datas-para-fevereiro-e-sera-na-india/2025-02-05T13:26:32+00:00https://healthtalks.newsfarma.pt/gil-silva-encontro-renal-2024-correu-muito-bem-e-e-para-repetir-nas-ilhas-2/2025-02-07T11:17:56+00:00https://healthtalks.newsfarma.pt/cirurgia-metabolica-e-contracecao-desafios-e-cuidados-para-mulheres-em-idade-fertil/2025-02-06T18:24:58+00:00https://healthtalks.newsfarma.pt/alargamento-do-rastreio-do-cancro-da-mama-vai-abranger-mais-400-mil-mulheres/2025-02-06T18:27:17+00:00https://healthtalks.newsfarma.pt/saude-da-mulher-pode-fazer-crescer-a-economia-global-um-triliao-de-dolares-por-ano/2025-02-06T18:32:07+00:00https://healthtalks.newsfarma.pt/papel-do-teste-genomico-na-decisao-terapeutica-em-mulheres-pre-menopausicas/2025-02-06T18:37:06+00:00https://healthtalks.newsfarma.pt/associacao-de-menopausa-alerta-para-praticas-nao-reguladas-que-ameacam-saude-das-mulheres/2025-02-06T18:39:24+00:00https://healthtalks.newsfarma.pt/longevidade-aumenta-mas-saude-das-mulheres-ainda-e-esquecida/2025-02-06T18:40:38+00:00https://healthtalks.newsfarma.pt/mulheres-com-obesidade-conversem-perguntem-o-que-elas-sentem-o-que-as-perturba-e-o-que-esperam/2025-02-06T18:45:58+00:00https://healthtalks.newsfarma.pt/gestao-de-peso-e-menopausa-importancia-da-intervencao-psicologica/2025-02-06T18:49:09+00:00https://healthtalks.newsfarma.pt/fmup-publica-estudo-sobre-dores-menstruais-e-a-sua-relacao-com-endometriose/2025-02-06T18:51:13+00:00https://healthtalks.newsfarma.pt/63-das-mulheres-afirmam-que-a-menopausa-impacta-negativamente-o-seu-dia-a-dia-no-trabalho-refere-estudo/2025-02-07T10:12:17+00:00https://healthtalks.newsfarma.pt/instituto-noruegues-afirma-que-ia-pode-identificar-risco-de-cancro-na-mama-anos-antes-do-diagnostico/2025-02-07T10:14:08+00:00https://healthtalks.newsfarma.pt/estudo-indica-que-endometriose-esta-associada-a-experiencias-traumaticas/2025-02-07T10:17:25+00:00https://healthtalks.newsfarma.pt/lpcc-avanca-este-mes-com-alargamento-do-rastreio-do-cancro-da-mama/2025-02-07T10:21:38+00:00https://healthtalks.newsfarma.pt/bolsa-lpcc-atribuida-a-projeto-na-area-do-cancro-do-endometrio-e-endometriose/2025-02-07T10:23:39+00:00https://healthtalks.newsfarma.pt/do-stress-a-concecao-os-desafios-mentais-da-fertilidade/2025-02-07T10:31:32+00:00https://healthtalks.newsfarma.pt/falsos-mitos-sobre-sindrome-dos-ovarios-poliquisticos/2025-02-07T10:30:55+00:00https://healthtalks.newsfarma.pt/advance-training-em-contracecao-intrauterina-cada-mulher-e-unica-e-e-fundamental-disponibilizar-opcoes-diversificadas/2025-02-28T10:59:27+00:00https://healthtalks.newsfarma.pt/submetido-pedido-de-aprovacao-de-finerenona-para-insuficiencia-cardiaca-na-ue/2025-02-07T11:18:26+00:00https://healthtalks.newsfarma.pt/area-cardiovascular-e-saude-da-mulher-sao-as-prioridades-da-bayer-para-2025/2025-02-07T10:59:58+00:00https://healthtalks.newsfarma.pt/medicamento-recebe-parecer-positivo-do-chmp-para-o-tratamento-da-cardiomiopatia-amiloide-por-transtirretina/2025-02-07T11:07:57+00:00https://healthtalks.newsfarma.pt/bayer-apoia-mais-uma-edicao-do-premio-de-risco-cardiovascular-dr-pedro-marques-da-silva/2025-02-07T11:12:25+00:00https://healthtalks.newsfarma.pt/desmistificar-o-tratamento-dos-doentes-cardiorrenais-estamos-a-fazer-um-otimo-caminho/2025-02-28T12:10:34+00:00https://healthtalks.newsfarma.pt/a-finerenona-surge-como-um-pilar-no-tratamento-da-doenca-renal-cronica-diabetica/2025-02-28T12:10:13+00:00https://healthtalks.newsfarma.pt/tratamento-dos-doentes-cardiorrenais-durante-anos-nao-tivemos-novidades-e-agora-temos-a-finerenona-que-veio-atrasar-a-progressao-da-doenca/2025-02-21T17:29:43+00:00https://healthtalks.newsfarma.pt/xxiv-simposio-de-atualizacao-em-nefrologia-uma-abordagem-feita-a-medida/2025-02-24T13:22:42+00:00https://healthtalks.newsfarma.pt/o-maior-premio-nacional-de-investigacao-em-nefrologia-e-entregue-em-fevereiro/2025-02-24T13:18:59+00:00https://healthtalks.newsfarma.pt/fmup-investigadores-testam-farmaco-promissor-no-tratamento-da-infertilidade/2025-02-27T13:06:13+00:00https://healthtalks.newsfarma.pt/diabetes-como-condutora-de-complicacoes-cardiacas-e-renais-a-visao-de-silvestre-abreu/2025-02-27T17:07:31+00:00https://healthtalks.newsfarma.pt/endocrinologia-no-feminino-redefinir-a-menopausa/2025-02-27T17:10:22+00:00https://healthtalks.newsfarma.pt/clinica-de-insuficiencia-cardiaca-em-cascais-resiliencia-multidisciplinaridade-e-inovacao/2025-03-03T15:12:12+00:00https://healthtalks.newsfarma.pt/equipa-de-investigadores-da-universidade-da-maia-e-da-nephrocare-distinguida-com-maior-premio-de-investigacao-na-area-da-nefrologia/2025-03-03T12:27:34+00:00https://healthtalks.newsfarma.pt/unidade-de-insuficiencia-cardiaca-avancada-do-hospital-de-santa-cruz-uma-jornada-de-esperanca-e-inovacao/2025-03-05T16:32:37+00:00https://healthtalks.newsfarma.pt/80-dos-portugueses-no-ultimo-estadio-da-doenca-renal-cronica-fazem-hemodialise/2025-03-05T14:40:13+00:00https://healthtalks.newsfarma.pt/essatla-reforca-oferta-formativa-para-a-area-de-enfermagem-com-pos-graduacao-em-dialise/2025-03-12T14:13:46+00:00https://healthtalks.newsfarma.pt/ulssm-realiza-com-sucesso-os-primeiros-implantes-do-cdi-extravascular/2025-03-12T14:17:48+00:00https://healthtalks.newsfarma.pt/aumento-da-esperanca-de-vida-abranda-na-europa-devido-a-doencas-cardiovasculares/2025-03-12T14:22:14+00:00https://healthtalks.newsfarma.pt/desconhecimento-sobre-hipertensao-arterial-pulmonar-afeta-90-dos-portugueses/2025-03-12T14:24:56+00:00https://healthtalks.newsfarma.pt/farmaco-para-diabetes-tipo-2-mostra-se-eficaz-para-tratar-a-infertilidade/2025-03-12T14:26:46+00:00https://healthtalks.newsfarma.pt/a-diabetes-e-uma-das-principais-causas-de-doenca-renal-cronica/2025-03-12T16:59:35+00:00https://healthtalks.newsfarma.pt/mais-de-30-dos-portugueses-nao-sabe-que-a-doenca-renal-cronica-pode-ser-prevenida/2025-03-13T11:10:57+00:00https://healthtalks.newsfarma.pt/planeamento-da-gravidez-em-mulheres-com-diabetes-continua-a-ser-um-desafio-alerta-especialista/2025-03-17T09:49:29+00:00https://healthtalks.newsfarma.pt/peritos-identificam-falhas-no-diagnostico-a-doenca-renal-cronica/2025-03-17T10:19:50+00:00https://healthtalks.newsfarma.pt/v-jornadas-do-sono-cuf-acontecem-em-abril/2025-03-17T14:54:06+00:00https://healthtalks.newsfarma.pt/tratamento-da-drc-e-diabetes-tipo-2-a-perspetiva-da-mgf/2025-03-17T15:11:54+00:00https://healthtalks.newsfarma.pt/armamentario-terapeutico-mais-completo-com-farmaco-para-a-doenca-renal-diabetica/2025-03-17T15:14:39+00:00https://healthtalks.newsfarma.pt/terapeutica-para-combater-a-diabetes-na-drc-temos-de-explicar-ao-doente-que-e-um-beneficio/2025-03-17T15:19:44+00:00https://healthtalks.newsfarma.pt/como-combater-a-doenca-renal-cronica-diabetica/2025-03-17T15:19:12+00:00https://healthtalks.newsfarma.pt/diabetes-e-doenca-renal-cronica-os-avancos-terapeuticos-por-joana-louro/2025-03-17T15:21:48+00:00https://healthtalks.newsfarma.pt/temos-ao-nosso-dispor-mais-e-melhores-farmacos-para-tratar-a-diabetes-associada-a-doenca-renal-cronica/2025-03-17T15:33:15+00:00https://healthtalks.newsfarma.pt/aprovado-regime-de-faltas-justificadas-para-mulheres-com-endometriose/2025-03-17T16:27:56+00:00https://healthtalks.newsfarma.pt/mulheres-com-endometriose-vao-ter-faltas-justificadas-ao-trabalho-a-partir-de-abril/2025-03-27T17:30:21+00:00https://healthtalks.newsfarma.pt/estudo-mostra-que-23-das-mulheres-ja-sentiram-ansiedade-por-falta-de-produtos-menstruais/2025-04-08T12:26:12+01:00https://healthtalks.newsfarma.pt/menopausa-com-o-tempo-o-medico-de-familia-vai-estar-preparado-para-tratar-sem-qualquer-risco/2025-04-09T17:26:08+01:00https://healthtalks.newsfarma.pt/contracecao-praticar-a-liberdade-de-escolha/2025-04-10T12:40:11+01:00https://healthtalks.newsfarma.pt/incontinencia-urinaria-nas-mulheres-vai-a-debate-na-fmup/2025-04-29T11:00:54+01:00https://healthtalks.newsfarma.pt/a-fertilidade-comeca-no-prato-o-papel-da-nutricao-na-saude-reprodutiva/2025-05-07T17:08:29+01:00https://healthtalks.newsfarma.pt/um-em-cada-seis-portugueses-com-mais-de-50-anos-vive-com-insuficiencia-cardiaca/2025-05-07T17:19:22+01:00https://healthtalks.newsfarma.pt/portugal-dados-mostram-que-a-pilula-e-o-contracetivo-mais-usado-pelos-jovens-com-47-das-preferencias/2025-05-07T17:28:54+01:00https://healthtalks.newsfarma.pt/dispositivos-intrauterinos-na-adolescencia-pos-aborto-pos-parto-e-perimenopausa-a-perspetiva-de-rafaela-ventura/2025-05-13T14:52:05+01:00https://healthtalks.newsfarma.pt/diu-e-doencas-cardiovasculares-uma-opcao-contracetiva-segura/2025-05-13T14:47:27+01:00https://healthtalks.newsfarma.pt/spg-pede-criacao-de-centros-de-referencia-para-enfrentar-cancro-do-ovario/2025-05-13T14:50:57+01:00https://healthtalks.newsfarma.pt/insuficiencia-cardiaca-uma-doenca-sistemica-alem-do-coracao/2025-05-14T10:23:09+01:00https://healthtalks.newsfarma.pt/nova-abordagem-terapeutica-em-doentes-em-fase-de-agudizacao-da-insuficiencia-cardiaca/2025-05-14T10:26:46+01:00https://healthtalks.newsfarma.pt/desvendando-o-potencial-de-uma-nova-terapeutica-no-tratamento-dos-doentes-cardiorrenais/2025-05-14T10:34:44+01:00https://healthtalks.newsfarma.pt/novo-pilar-no-tratamento-da-insuficiencia-cardiaca-com-fracao-de-ejecao-preservada/2025-05-14T10:38:30+01:00https://healthtalks.newsfarma.pt/estrategias-farmacologicas-coordenadas-no-tratamento-da-sindrome-cardiorrenometabolica/2025-05-14T11:54:54+01:00https://healthtalks.newsfarma.pt/avancos-significativos-no-tratamento-da-insuficiencia-cardiaca-com-fracao-de-ejecao-preservada/2025-05-14T10:46:33+01:00https://healthtalks.newsfarma.pt/o-potencial-quinto-pilar-no-tratamento-da-insuficiencia-cardiaca-com-fracao-de-ejecao-reduzida/2025-05-14T10:48:35+01:00https://healthtalks.newsfarma.pt/sindrome-crm-na-geriatria-se-o-diagnostico-for-precoce-espera-se-uma-reducao-de-complicacoes-graves-e-um-envelhecimento-com-mais-qualidade-de-vida/2025-05-16T15:08:39+01:00https://healthtalks.newsfarma.pt/medicina-interna-e-a-sindrome-crm-temos-de-ter-uma-abordagem-mais-proativa/2025-05-16T15:10:42+01:00https://healthtalks.newsfarma.pt/insuficiencia-cardiaca-no-cnmi-o-primeiro-passo-e-uma-boa-formacao-de-como-se-pode-manejar-os-farmacos-e-vamos-ver-menos-descompensacao-melhor-qualidade-de-vida-e-doentes-com-prognostico-me/2025-05-16T15:03:04+01:00https://healthtalks.newsfarma.pt/e-fundamental-que-se-faca-pesquisa-da-lesao-de-orgao-alvo-e-e-mandatorio-atuar-desde-o-inicio/2025-05-16T14:59:34+01:00https://healthtalks.newsfarma.pt/o-bom-funcionamento-da-tiroide-como-contributo-para-a-fertilidade/2025-05-21T11:05:40+01:00https://healthtalks.newsfarma.pt/conselho-dos-jovens-cardiologistas-queremos-que-seja-uma-grande-familia/2025-05-21T11:18:41+01:00https://healthtalks.newsfarma.pt/portugal-cerca-de-12-milhoes-de-mulheres-estao-atualmente-na-fase-da-menopausa/2025-05-22T11:09:13+01:00https://healthtalks.newsfarma.pt/perimenopausa-diagnostico-contracecao-e-abordagem-personalizada/2025-05-26T18:05:30+01:00https://healthtalks.newsfarma.pt/diversidade-contracetiva-aconselhamento-e-escolha-personalizada/2025-05-27T09:52:34+01:00https://healthtalks.newsfarma.pt/integracao-de-cuidados-e-essencial-para-uma-resposta-eficaz-na-saude-da-mulher-defende-paulo-santos/2025-05-27T10:05:08+01:00https://healthtalks.newsfarma.pt/hormonafobia-e-desinformacao-os-novos-obstaculos-no-planeamento-familiar/2025-05-27T10:12:44+01:00https://healthtalks.newsfarma.pt/saude-da-mulher-ponte-entre-especialidades-e-cuidados-de-saude-primarios/2025-05-27T10:25:03+01:00https://healthtalks.newsfarma.pt/rita-nortadas-se-formos-mais-ativos-no-diagnostico-e-mais-precoces-na-intervencao-temos-muito-a-ganhar/2025-06-25T10:37:52+01:00https://healthtalks.newsfarma.pt/pedro-moraes-sarmento-iniciar-inibidor-de-sglt2-e-finerenona-no-doente-com-fracao-de-ejecao-preservada-e-praticamente-incontornavel/2025-06-25T10:38:22+01:00https://healthtalks.newsfarma.pt/diogo-cruz-aproveitar-cada-contacto-para-avaliar-o-risco-cardiovascular/2025-06-25T10:38:32+01:00https://healthtalks.newsfarma.pt/rafaela-verissimo-queremos-sobretudo-que-os-doentes-vivam-mais-anos-com-mais-qualidade-de-vida/2025-06-25T10:38:45+01:00https://healthtalks.newsfarma.pt/beatriz-sa-os-internistas-sao-os-grandes-gestores-dos-doentes/2025-06-25T10:39:03+01:00https://healthtalks.newsfarma.pt/marcel-guerreiro-temos-ferramentas-agora-e-preciso-combater-a-inercia-terapeutica/2025-06-25T10:39:37+01:00https://healthtalks.newsfarma.pt/mariana-alves-a-finerenona-e-uma-nova-arma-extremamente-eficaz/2025-06-25T10:40:09+01:00https://healthtalks.newsfarma.pt/joao-francisco-soares-finerenona-e-o-potencial-ainda-por-explorar/2025-06-25T10:40:44+01:00https://healthtalks.newsfarma.pt/flavia-freitas-a-finerenona-podera-revelar-se-um-farmaco-transformador/2025-06-25T10:41:33+01:00https://healthtalks.newsfarma.pt/estudo-demonstra-nova-estrategia-para-travar-calcificacao-vascular-com-efeito-distinto-entre-sexos/2025-06-26T12:27:03+01:00https://healthtalks.newsfarma.pt/avancos-em-novo-estudo-clinico-para-tratamento-inovador-da-fibrilhacao-auricular/2025-06-26T13:12:40+01:00https://healthtalks.newsfarma.pt/premio-de-risco-cardiovascular-dr-pedro-marques-da-silva-estamos-entusiasmados-com-a-panoplia-de-opcoes-que-temos-pela-frente-do-ponto-de-vista-da-investigacao/2025-06-27T16:18:53+01:00https://healthtalks.newsfarma.pt/xvi-congresso-portugues-de-ginecologia-e-uma-edicao-especial-porque-precede-a-comemoracao-dos-50-anos-da-spg/2025-07-07T15:01:41+01:00https://healthtalks.newsfarma.pt/ginecologistas-devem-perguntar-sobre-a-menstruacao-com-um-questionario-consistente-e-profundo/2025-07-07T15:06:18+01:00https://healthtalks.newsfarma.pt/como-deve-ser-feita-a-gestao-da-hemorragia-menstrual-excessiva-e-da-dismenorreia/2025-07-07T15:09:36+01:00https://healthtalks.newsfarma.pt/supressao-menstrual-na-adolescencia-pode-fazer-sentido-em-varias-situacoes/2025-07-07T15:13:19+01:00https://healthtalks.newsfarma.pt/a-saude-da-mulher-e-importante-e-faz-sentido-haver-articulacao-com-outras-especialidades/2025-07-07T15:16:19+01:00https://healthtalks.newsfarma.pt/trazer-conforto-e-solucoes-para-problemas-de-saude-feminina-ajuda-a-reduzir-o-estigma-e-mulheres-saudaveis-tem-um-impacto-positivo-como-um-todo-participando-ativamente-em-todos-os-aspetos-d/2025-09-24T17:02:11+01:00https://healthtalks.newsfarma.pt/universidade-do-minho-desenvolve-vacina-contra-a-candidiase-invasiva/2025-07-17T10:28:46+01:00https://healthtalks.newsfarma.pt/cristina-nogueira-da-silva-distinguida-pela-sua-investigacao-sobre-adenomiose/2025-07-17T10:41:52+01:00https://healthtalks.newsfarma.pt/estudo-confidence-reforca-a-importancia-da-abordagem-precoce-e-simultanea-na-gestao-da-drc-em-doentes-com-dt2/2025-07-22T09:30:26+01:00https://healthtalks.newsfarma.pt/fda-aprovou-finerenona-para-nova-indicacao-em-doentes-com-insuficiencia-cardiaca-com-fracao-de-ejecao-do-ventriculo-esquerdo-%e2%89%a5-40/2025-07-31T14:55:09+01:00https://healthtalks.newsfarma.pt/mulheres-com-maior-circunferencia-da-cintura-tem-risco-aumentado-de-morte-independentemente-do-imc/2025-07-31T12:16:33+01:00https://healthtalks.newsfarma.pt/heart-failure-2025-qual-e-o-beneficio-de-terapeuticas-que-reduzem-as-rehospitalizacoes-por-insuficiencia-cardiaca-e-o-papel-da-finerenona/2025-08-01T10:08:47+01:00https://healthtalks.newsfarma.pt/finearts-hf-subanalise-realca-a-necessidade-de-manutencao-terapeutica-em-doentes-com-ic-com-fracao-de-ejecao-preservada-e-ligeiramente-reduzida/2025-08-01T10:12:51+01:00https://healthtalks.newsfarma.pt/estudo-victor-vericiguat-reduz-mortalidade-cv-e-por-todas-as-causas-em-doentes-com-ic/2025-09-12T17:49:37+01:00https://healthtalks.newsfarma.pt/ic-com-fracao-de-ejecao-preservada-ou-ligeiramente-deprimida-nova-evidencia-de-mais-um-potente-medicamento-para-tratar-estes-doentes/2025-09-12T17:57:21+01:00https://healthtalks.newsfarma.pt/novos-dados-para-o-tratamento-da-insuficiencia-cardiaca-em-destaque-no-esc-2025/2025-09-12T18:06:31+01:00https://healthtalks.newsfarma.pt/reduzir-o-risco-residual-em-doentes-com-insuficiencia-cardiaca-evidencia-do-estudo-victor/2025-09-16T09:43:04+01:00https://healthtalks.newsfarma.pt/nova-abordagem-integrada-para-doentes-com-insuficiencia-cardiaca-e-doenca-renal-cronica/2025-09-16T09:42:47+01:00https://healthtalks.newsfarma.pt/novidades-que-vao-impactar-o-futuro-do-tratamento-da-insuficiencia-cardiaca/2025-09-17T09:19:07+01:00https://healthtalks.newsfarma.pt/a-evolucao-que-faltava-no-tratamento-da-icfer-vericiguat-como-novo-pilar-terapeutico/2025-09-23T10:40:54+01:00https://healthtalks.newsfarma.pt/estabilizacao-otimizada-da-transtirretina-transforma-prognostico-na-amiloidose-cardiaca/2025-10-14T16:08:50+01:00https://healthtalks.newsfarma.pt/attr-cm-indiscutivelmente-estabilizar-a-transtirretina-e-uma-acao-terapeutica-com-enorme-potencial/2025-10-03T11:52:40+01:00https://healthtalks.newsfarma.pt/attr-cm-impacto-de-uma-nova-terapeutica-nas-hospitalizacoes-mortalidade-e-parametros-de-qualidade-de-vida/2025-09-29T15:37:41+01:00https://healthtalks.newsfarma.pt/attribute-cm-o-estudo-que-revelou-um-avanco-promissor-no-tratamento-da-amiloidose-cardiaca/2025-10-03T12:27:14+01:00https://healthtalks.newsfarma.pt/roteiro-terapeutico-da-attr-cm-do-diagnostico-a-pratica-clinica/2025-10-03T12:36:32+01:00https://healthtalks.newsfarma.pt/estabilizacao-da-ttr-e-objetivos-terapeuticos-da-evidencia-a-pratica-clinica/2025-10-03T12:42:29+01:00https://healthtalks.newsfarma.pt/ivg-o-que-falta-fazer-no-pais-e-qual-o-impacto-da-imigracao/2025-10-07T10:38:11+01:00https://healthtalks.newsfarma.pt/contracecao-para-lgbtq-garantir-um-ambiente-seguro-e-combater-a-desinformacao/2025-10-07T10:47:51+01:00https://healthtalks.newsfarma.pt/a-contracecao-hormonal-e-um-medicamento-que-ultrapassa-largamente-o-seu-proposito-primario/2025-10-07T10:51:25+01:00https://healthtalks.newsfarma.pt/os-melhores-momentos-da-14-a-reuniao-nacional-da-sociedade-portuguesa-da-contracepcao/2025-10-07T11:03:33+01:00https://healthtalks.newsfarma.pt/a-importancia-da-estabilizacao-da-transtirretina-e-o-impacto-na-qualidade-de-vida-do-doente-com-attr-cm/2025-12-12T10:52:13+00:00https://healthtalks.newsfarma.pt/nova-abordagem-para-a-estabilizacao-da-transtirretina-na-attr-cm-o-que-nos-diz-a-evidencia/2025-12-12T15:55:29+00:00https://healthtalks.newsfarma.pt/attr-cm-o-impacto-da-estabilizacao-da-transtirretina-nos-desfechos-clinicos-e-marcadores-laboratoriais/2026-03-03T14:48:38+00:00https://healthtalks.newsfarma.pt/da-estabilizacao-superior-a-90-aos-beneficios-clinicos-consistentes-na-attr-cm-o-que-diz-a-evidencia/2026-03-03T14:48:29+00:00https://healthtalks.newsfarma.pt/infarmed-aprova-financiamento-de-novo-estabilizador-da-ttr-para-miocardiopatia-amiloide/2026-03-03T14:54:55+00:00